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Abstract 
 
 
In the last decades, nanomaterials have arisen a great interest for the scientific 
community because of their special properties derived from their small size. In 
particular, carbon nanomaterials (CNMs) present a unique set of intrinsic 
electronic, magnetic and optical properties. In addition, CNMs present high 
chemical versatility and biocompatibility, which makes them great candidates in 
a wide range of different applications. 
Carbon nanotubes (CNTs) and graphene are the most promising CNMs for 
several applications. However, the functionalization (i.e. the chemical 
modification) of their surface is an important requirement for some of these 
applications. The aim of this work is to manufacture a biosensor based on 
difunctionalized CNTs and graphene, for the detection of prostate cancer. 
In the present thesis work, the covalent difunctionalization of CNTs and 
subsequent modification of the introduced functional groups is presented in 
Chapter 2. Double-walled CNTs (DWCNTs) were difunctionalized through 
aryldiazonium addition, incorporating to their outer wall two molecular moieties 
which only differ on the protecting group of an amino function. Two different 
approaches were followed: the sequential addition of each aniline containing a 
kind of protected amino group in two steps or the addition of both in one 
reaction step (one-pot difunctionalization). The difunctionalization of oxidized 
multi-walled CNTs (ox-MWCNTs) by combination of the aryldiazionium addition 
and the amidation of carboxylic groups was also exploited. 
In Chapter 3, the functionalization of different graphene derivatives is 
described. Several approaches were studied with varying results. In a first study, 
reduced graphene oxide (rGO) was modified in only one functionalization step; 
introducing the desired difunctionality in the subsequent modification of the 
introduced functional group. Negative results were obtained at the one-pot 
difunctionalization of rGO, mimicking the procedure which was used for 
DWCNTs. However, we succeeded in the addition of sulfur radicals to graphene 
oxide (GO), with consequent reduction of GO, followed by the amidation of 
residual carboxylic groups present in rGO. Finally, the non-covalent modification 
of graphene obtained by chemical vapor deposition (CVDG) was exploited. 
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Finally, the manufacturing of an immunosensor for the detection of prostate 
cancer biomarker prostate-specific membrane antigen (PSMA) using 
difunctionalized CNTs is presented in Chapter 4. Electrochemiluminescence 
(ECL) was used as signal for the detection. Different immunosensors were 
developed composed by difunctionalized ox-MWCNTs or DWCNTs as 
components, obtaining different results depending on the employed CNT. The 
different manufactured immunosensors were characterized in terms of limit of 
detection (LOD) and limit of quantification (LOQ). In addition, the ECL 
enhancement due to the presence of the CNTs could be demonstrated by 
comparison with a similar ECL immunosensor without the CNTs. 
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Riassunto 
 
 
Negli ultimi decenni, i nanomateriali hanno sortito un grande interesse per la 
comunità scientifica a causa delle loro particolari proprietà derivate dalle loro 
piccole dimensioni. In particolare, i nanomateriali di carbonio (CNMs) 
presentano una serie unica di proprietà elettroniche, magnetiche e ottiche 
intrinseche. Inoltre, i CNMs presentano elevata versatilità chimica e 
biocompatibilità, che li rende ottimi candidati in una vasta gamma di 
applicazioni diversi. 
I nanotubi di carbonio (CNTs) e il grafene sono i CNMs più promettenti per 
diverse applicazioni. Tuttavia, la funzionalizzazione (cioè la modificazione 
chimica) della loro superficie è un requisito importante per alcune di queste 
applicazioni. Lo scopo di questo lavoro è di produrre un biosensore basato su 
CNTs e grafene difunzionalizzati, per il rilevamento del cancro della prostata. 
Nel presente lavoro di tesi, la difunzionalizzazione covalente di CNTs e la 
successiva modifica dei gruppi funzionali introdotti sono presentate nel Capitolo 
2. CNTs a parete doppia (DWCNTs) sono stati difunzionalizzati attraverso la 
aggiunta di sali di arildiazonio, incorporando alla loro parete esterna due frazioni 
molecolari che differiscono solo su il gruppo protettore di una funzione 
amminica. Due approcci diversi sono stati seguiti: l'aggiunta sequenziale di ogni 
anilina contenente una sorta di gruppo amminico protetto in due passi, o 
l'aggiunta di entrambi in uno stadio di reazione (one-pot difunzionalizzazione). 
La difunzionalizzazione di CNTs a parete multipla ossidati (ox-MWCNT) 
attraverso la combinazione di aggiunta della sale di arildiaziono e ammidazione 
dei gruppi carbossilici è stata anche sfruttata. 
Nel Capitolo 3, la funzionalizzazione di diversi derivati del grafene è descritta. 
Diversi approcci sono stati studiati con risultati variabili. In un primo studio, 
ossido di grafene ridotto (rGO) è stato modificato in un unico passaggio di 
funzionalizzazione; introducendo la difunzionalità desiderata nella successiva 
modifica del gruppo funzionale introdotto. Risultati negativi sono stati ottenuti 
nella one-pot difunzionalizzazione di rGO, imitando il procedimento che è stato 
utilizzato per i DWCNTs. Tuttavia, siamo riusciti a l'aggiunta di radicali zolfo 
al’ossido di grafene (GO), con conseguente riduzione del GO, seguita dalla 
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4 
ammidazione dei gruppi carbossilici residuali presenti in rGO. Infine, la 
modificazione non-covalente di grafene ottenuto per deposizione chimica da 
fase vapore (CVDG) è stata sfruttata. 
Infine, la fabbricazione di un immunosensore per il rilevamento del 
biomarcatore del cancro della prostata prostate-specific membrane antigen 
(PSMA) utilizzando CNTs difunzionalizzati è presentata nel Capitolo 4. 
Elettrochemiluminescenza (ECL) è stata utilizzata come segnale per il 
rilevamento. Diversi immunosensori sono stati sviluppati composti da ox-
MWCNTs o DWCNTs difunzionalizzati come componenti, ottenendo risultati 
diversi a seconda del CNT impiegato. I diversi immunosensori manufatti sono 
stati caratterizzati in termini di limite di rivelabilità (LOD) e limite di 
quantificazione (LOQ). Inoltre, il miglioramento della ECL dovuto alla presenza 
dei CNTs può essere dimostrato per confronto con un immunosensore di ECL 
simile senza CNTs. 
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Chapter 1  
Introduction 
 
 
Carbon can be found in many allotropic forms, due to its capacity to form sp2 or 
sp3 bonds between individual carbon atoms. On the other hand, nanomaterials 
are defined as materials that are sized, in at least one dimension, between 1 and 
100 nm. Hence, carbon nanomaterials (CNMs) are those allotropic forms of 
carbon with at least a single unit sized in the nanoscale (1 – 100 nm). 
1.1. Carbon nanomaterials: Nanotubes and graphene 
CNMs exhibit a huge diversity in structure (Figure 1). They can be classified 
according to the number of dimensions that are confined to the nanoscale size: 
zero-dimensional, as carbon dots; one-dimensional, as carbon nanotubes 
(CNTs); and two-dimensional, as graphene.1 
 
Figure 1. Most representative examples of CNMs. Adapted from Baptista et al. 2015.
1
 
CNMs present a unique set of intrinsic electronic, magnetic and optical 
properties, chemical versatility and biocompability. For this reason, CNMs have 
been broadly studied and used for several applications.2 However, among them, 
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CNTs and graphene (and its derivatives) have received the greatest interest, 
especially for sensing applications.1 
Graphene 
Since its discovery in 2004,3 graphene has attracted the attention of researchers 
from different fields. Graphene is defined as a single layer of graphite and it is 
composed by a honeycomb lattice of sp2 hybridized carbon atoms (Figure 2).  
 
Figure 2. Two-dimensional structure of graphene. Both types of edges, zig-zag (green) 
and armchair (blue), are displayed. 
Graphene can present two types of achiral edges, zig-zag or amchair, defined by 
the relative orientation of hexagons (Figure 2).4 Properties and reactivity of each 
edge is different, however, most of the synthesized graphenes present a 
mixture of both edges.  
Another structural classification of graphene is defined according to the number 
of two-dimensional layers that are present. In this way, the term monolayer 
graphene is used for a individual sheet of carbon atoms, bilayer graphene 
corresponds to 2 stacked graphene sheets and few-layer graphene defines the 
material which presents between 2 and 5 stacked layers of graphene. 
Carbon nanotubes 
Discovered in 1991 by Iijima,5 CNTs are defined as a graphene sheet rolled up in 
a cylindrical shape (Figure 3). They are exclusively composed by carbon, in a sp2 
hybridization, creating a hexagonal network. 
Introduction 
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Figure 3. Structure of CNTs, described as a rolled-up graphene sheet. Adapted from 
Geim et al. 2007.
6
 
A general classification for CNTs is based on the number of layers (also called 
walls) they are made of. Hence, we have two groups of CNTs:7 
 Single-walled carbon nanotubes (SWCNTs, Figure 4, A and B). They are a 
single cylinder. The inner diameter ranges from 0.35 to 2.5 nm and the length 
up to several micrometers. 
 Multi-walled carbon nanotubes (MWCNTs, Figure 4, A and C). They are 
made of two or more concentric cylindrical sheets. Their diameter ranges 
between 3 and 50 nm. It is worth mentioning that an interesting type of CNTs 
within this group are double-walled carbon nanotubes (DWCNTs), which are 
composed of two cylindrical sheets. 
 
 
Figure 4. A) Shematic representation of SWCNTs (left) and MWCNTs (right).
8
 B) and C) 
TEM images of SWCNTs and MWCNTs, respectively. Adapted from Haffner et al. 2001.
7
 
A) 
B) C) 
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In addition, CNTs can be classified according to the different ways in which the 
graphene sheet is rolled up.9 In this classification, the structure of CNTs is 
described by two indices, n and m, that are related to two vectors: translational 
vector (T) and chiral vector (Ch); and the chiral angle,  (Figure 5). The vector T is 
parallel to the CNT axis, and the vector Ch is orthogonal to T and connects two 
equivalent carbon atoms. Ch can be defined by Equation 1, where a1 and a2 are 
the graphene lattice vectors and n and m are the integers. The chiral angle, , is 
the angle that Ch makes with a1, which corresponds to the zig-zag direction. 
Equation 1                
 
 
Figure 5. Graphene sheet defining the chiral angle . The shadowed rectangle, delimited 
by the vectors T and Ch, corresponds to the area of the unit cell of the tube. 
With this defined concepts, CNTs can be classified in three categories (Figure 6): 
 Zig-zag. The case with  = 0, which implies that m = 0. In this case, Ch is 
defined by (n, 0). In other words, Ch is equal to a1. 
 Armchair. The case with  = 30 º, which implies n = m and Ch is defined 
by (n, n). 
 Chiral. In this case n ≠ m ≠ 0, which implies 0 <  < 30 º. 
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Figure 6. Zig-zag (left) and armchair (right) CNTs. The arrows represent the axis, parallel 
to the vector, T. Adapted from Ortolani et al. 2010.
10
 
1.1.1. Production of graphene and carbon nanotubes 
Due to their unique and interesting properties, CNMs have promising 
applications. However, viable industrial applications require large scale and 
cost-effective production methods, without affecting the quality of final 
material. 
Large-scale production of CNTs was soon achieved after their discovery,11 and 
nowadays, different methods are used for mass production of high-quality 
CNTs. On the other hand, graphene production remains a challenge, since it is a 
younger material. Many different methods have been described, however, good 
quality graphene usually requires expensive techniques, while large scale 
production generally leads to a highly-defected material. Nevertheless, the 
presence of defects is not necessarily a disadvantage. For this reason, 
production method should be chosen according to the desired application.12 
Production methods for graphene can be classified in two categories: top-down, 
in which the stacked sheets of graphite are separated into individual graphene 
layers, and bottom-up, consisting on the direct formation of graphene from 
smaller carbon sources.13 Most of the processes for CNTs production are based 
in bottom-up approaches. 
1.1.1.1. Top-down methods for graphene production 
Top-down approaches are based on the breaking down of structures into their 
smaller components. Several techniques for obtaining graphene are based on 
the separation of the graphene layers of graphite. However, these techniques 
have not usually been applied for the large production of CNTs. 
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Micromechanical cleavage 
This method was the first technique for graphene obtaining.3 Also known as the 
“scotch tape” method, it consists on the separation of atomic layers of graphite 
using an adhesive tape. This simple and cheap process produces high-quality 
monolayer graphene, but its yield is very low (around 10 %) and it is not suitable 
for large-scale production. 
Mechanochemical treatment 
Ball-milling has been used to exfoliate graphite with the help of an intercalating 
agent, which penetrates between graphene layers, helping to their separation 
(Figure 7).14 The main advantage of this method is the large-scale production. 
However, few-layer and defected graphene is obtained.  
 
Figure 7. Mechanochemical exfoliation of graphite using ball-milling and melamine as 
intercalating agent. Adapted from Leon et al. 2011.
14a
 
Liquid-phase exfoliation 
A liquid environment can be used to exfoliate graphite by exploiting ultrasound 
to extract individual graphene layers.15  
During ultrasonication, shear forces and cavitation act on the bulk material 
inducing exfoliation. However, the main challenge is to obtain stable dispersions 
after sonication, which requires that attractive forces between solvent and 
graphene are bigger than between different graphene layers. Solvents with 
surface tension of approximately 40 mJ/m2 minimize interfacial tension 
between solvent and graphene, affording stable dispersions. Most common 
solvents used for graphene exfoliation are N-methyl-2-pyrrolidone (NMP), N,N-
dimethylformamide (DMF) and ortho-dichlorobenzene (ODCB).16 In addition, 
exfoliation of graphene has been achieved using perfluorinated aromatic 
molecules as solvents.17 
The main drawback of mentioned solvents is their toxicity. Thus, effort has been 
put into finding alternative solvents. For instance, the use of surfactants has 
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allowed the use of aqueous media for exfoliation. However, the main 
disadvantage of using surfactants is the difficulty of removing them after 
sonication.18 
Overall, liquid-phase exfoliation allows a large-scale production of graphene, but 
with low control on the quality. Another important disadvantage is the 
requirement of using large amounts of toxic substances. 
Reduction of graphene oxide 
Graphene oxide (GO), which has been known for a long time (it was first 
obtained in 1958) is produced by the oxidation of graphite with strong oxidants 
and concentrated acids.19  
The structure of GO contains two regions: aromatic regions and aliphatic regions 
with sp3 carbon atoms attached to oxygenated groups.20 The relative size of 
these regions depends on the grade of oxidation. The present oxygenated 
groups are epoxy and hydroxyl on the basal plane and carboxylic and carbonyl 
on the edges. 
Several methods describe the reduction of GO, including thermal or chemical 
reduction. Chemical methods require the use of a reductant, as hydrazine or 
sodium borohydride.21 Reduction of GO involves the removal of oxygenated 
groups, thus recovering aromaticity (Figure 8). However, the complete 
reduction of GO has not yet been achieved and the obtained material still 
presents defects (oxygenated groups and aliphatic regions).22 For this reason, 
instead of graphene, the obtained product is usually called reduced graphene 
oxide (rGO). 
 
Figure 8. Preparation of rGO by oxidation and subsequent reduction of graphite. 
1.1.1.2. Bottom-up methods for graphene and CNTs production 
Bottom-up approaches are based on the construction of structures by the 
assembling of smaller building blocks. These methods have been used for the 
production of both graphene and CNTs. 
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Graphene synthesis by thermal desorption of SiC 
Graphene is formed on a silicon carbide (SiC) substrate by sublimation of Si, 
when graphitization of excess of carbon atoms happens.23 This process requires 
very high temperatures (1100 – 1600 ºC) and a high-quality graphene is 
obtained. 
Chemical vapor deposition for graphene and CNTs 
Chemical vapor deposition (CVD) is the process which involves the deposition of 
a solid material on a substrate from a gaseous source. This method can be used 
for the synthesis of graphene and CNTs, leading to a very high quality material in 
both cases. 
For CNTs production, a catalytic metallic nanoparticle (NP) is heated (500 – 1000 
ºC) in a tube furnace with a hydrocarbon gas flow. The CNT grows as 
consequence of the dissociation of hydrocarbon molecules catalyzed by metal 
NP and saturation of carbon atoms in metal NP.24 With this method, 
characteristics of CNTs can be tuned by varying operating conditions as 
temperature, pressure, concentration and kind of hydrocarbon, reaction time 
and characteristics of the catalytic metal NP. For example, by using different NP 
sizes, CNTs with different diameters are obtained. 
Moreover, graphene has been produced by this method, using as catalytic 
substrate the flat surface of a transition metal, usually Ni or Cu.25 Large 
quantities of high quality graphene can be obtained with this approach. 
However, the main disadvantage is the necessity of transferring graphene from 
catalytic metal to the substrate required for the different applications. One of 
the most common transfer methods consists on coating graphene with a layer 
of polymethyl methacrylate (PMMA), followed by the etching of catalytic metal. 
Then, PMMA/graphene film is transferred to desired substrate and then, PMMA 
is removed (Figure 9). 
 
Figure 9. Transferring of CVD-grown graphene to a substrate using PMMA. Adapted 
from Zhang et al. 2012.
25
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Arc-discharge evaporation 
CNTs were discovered with this method.5 It consists on the production of an arc 
in a small gap between two graphite electrodes. This method is performed at 
very low pressures and high temperatures in the inner space between 
electrodes to sublimate carbon from the anode, creating a plasma. When 
carbon condensates at the cathode, it acquires the shape of CNTs. The presence 
of catalytic metals in the anode is required for the process. 
Large amounts of CNTs can be obtained with this method. However, CNTs 
produced by this approach are usually contaminated with other carbon forms 
and they require extensive purification. 
Laser ablation synthesis of CNTs 
Both MWCNTs and SWCNTs can be obtained by laser ablation.26 In this method, 
graphite is irradiated with laser under inert atmosphere. Because of this 
irradiation at high temperatures (ca. 1200 ºC), graphite vaporizes producing a 
soot which contains CNTs. With this method, the obtained CNTs present higher 
purity than arc-discharge CNTs. Nevertheless, the amount of material produced 
with laser ablation is lower. 
1.1.2. Characterization 
Reliable characterization techniques are extremely important to confirm the 
structure of CNMs and to recognize their possible modifications. Bellow, a brief 
introduction for characterization techniques used in this work is reported. 
Raman spectroscopy 
Raman spectroscopy is a very powerful technique to the characterization for sp2 
carbon materials, as CNMs. This spectroscopy, based on the study of inelastic 
scattering of monochromatic light irradiating a sample, provides structural 
information regarding defects, stacking of layers or crystalline size.27 
Both graphene and CNTs present some Raman-features in common (Figure 
10).27 The two dominant features in Raman spectrum are the graphite band (G 
band), which appears at around 1580 cm-1 and is associated with the 
longitudinal optical phonon mode, and the G’ band (or 2D band), which appears 
between 2500 – 2900 cm-1 and is a second-order dispersive effect. Another 
important band for graphene and CNTs is the disorder band (D band). This band 
appears at around 1530 cm-1 and is caused by the breathing modes of sp2 
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carbon rings, which requires a defect for its activation. Thus, the relative 
intensity of D to G is a good indicator for determining the number of defects in 
the sample.28 
Furthermore, the 2D band presents additional information for graphene 
characterization. Width, shape and relative intensity to G band depend on the 
number of stacked graphene layers. Because of this, monolayer graphene 
(Figure 10B) presents a 2D band with higher intensity than G band, bilayer 
graphene has 2D and G bands with comparable intensity, and few-layer 
graphene presents a broadening and decreasing intensity of 2D band as the 
number of layers increase (Figure 10C).29 
In addition, CNTs present a characteristic Raman feature, due to their cylindrical 
shape, the radial breathing mode (RBM). The RBM peaks, between 100 – 300 
cm-1, are caused by vibrations in the radial direction of the tube. Information 
about the (n,m) indices of the tube can be obtained from RBM peaks.9 
 
Figure 10. Raman spectra of A) DWCNTs, B) monolayer graphene and C) 2D band of 
different number of stacked layers of graphene. Adapted from Ferrari et al. 2006.
29
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Thermogravimetric analysis 
Thermogravimetric analysis (TGA) is a very important characterization technique 
in materials science. It is based on recording the weight of a sample as function 
of an increasing temperature, generally until 1000 ºC for CNMs. Great 
information regarding thermal stability or presence of other substances can be 
obtained with this method. 
This versatile technique can afford different information depending on the 
environment in which the experiment is performed. With air, all carbon material 
is degraded, giving information about the quantity of metal residues. In an inert 
atmosphere (under Ar or N2), the amount of bound organic moieties can be 
measured, since graphene and CNTs are stable upon heating in inert conditions. 
Microscopy techniques 
Graphene and CNTs can be visualized with nanometric resolution microscopy 
techniques. Morphological information, as diameter, length and number of 
walls of CNTs or thickness (number of layers) of graphene, is obtained with 
these techniques. Examples of commonly used microscopy techniques for 
graphene and CNTs are TEM, scanning electron microscope (SEM) or atomic-
force microscopy (AFM). 
 
Figure 11. TEM images of A) DWCNTs and B) Few-layer graphene. 
X-ray photoelectron spectroscopy 
X-ray photoelectron spectroscopy (XPS) is a very powerful technique which 
allows to detect, quantify and define the elemental composition of a sample. 
The sample is irradiated with X-rays, causing the emission of photoelectrons 
from sample surface. A photodetector measures the intensity and the binding 
energy of the generated photoelectrons. 
A) B) 
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Thus, the elemental composition of the graphene sample can be defined, since 
elemental identity and chemical state are strongly dependent with the binding 
energy. In addition, quantitative information about the elemental composition 
of graphene can be obtained with this technique. 
Kaiser test (KT) 
Traditionally used in peptide synthesis, this analytical method has also been 
used for the quantitative detection of primary amino groups present in 
functional groups introduced in CNTs and graphene by a colorimetric analysis.30 
KT is based in the specific reaction between primary amino groups and 
ninhydrin, which affords a product with a characteristic dark blue color (Figure 
12). By measuring the intensity of the corresponding peak in ultraviolet-visible 
(UV-Vis) spectrum, a quantitative amount of amino groups can be calculated. It 
is worth noting that ninhydrin reacts only with primary alkylic amines. Other 
amino groups, as secondary and tertiary amines or anilines cannot be detected 
with KT. 
 
Figure 12. Mechanism of KT in which ninhydrin reacts with a primary alkylic amine to 
afford a blue product.
31
 
1.1.3. Properties 
The theoretical and experimental studies of the properties of graphene and 
CNTs have arisen a great interest in the scientific community. However, these 
properties are strongly dependent with the structure of the CNMs. 
Electronic properties 
Theoretical electronic structure of graphene can be calculated considering two 
carbon atoms per unit cell. Graphene shows two conical points per Brillouin 
zone (the primitive unit cell in wave-vector space), where band crossing 
happens at Dirac points, K and K’ (Figure 13).32 These two points, K and K’, 
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coincide with the Fermi leveli and separate conduction and valence bands, 
revealing a zero band gap for graphene. However, a band splitting takes place in 
bilayer graphene, creating a band gap of 0.8 meV.33 Although this value is too 
small to be experimentally detected, band gap increases with the number of 
layers. 
 
Figure 13. Energy bands of graphene near the Fermi level. Adapted from Ando, 2009.
32a
 
On the other hand, electronic structure of CNTs can be investigated considering 
them as rolled-up graphene sheets. Consequently, electronic properties of CNTs 
will depend on the angle in which graphene sheet is rolled up, defined by the 
indices (n, m). Hence, armchair CNTs (n, n) present metallic behavior, since they 
present a finite value in the density of states at the Fermi energy (Figure 14A), 
and zig-zag CNTs (n, 0) are semiconductors, since they present a small gap at the 
Fermi level (Figure 14B).34 
 
Figure 14. Electronic density of states of A) metallic armchair (5,5) SWCNT and B) 
semiconductor zig-zag (7, 0) SWCNT. Adapted from Charlier, 2002.
34 
 
                                                          
i
 IUPAC recommended definition for “Fermi level”: The chemical potential of electrons in 
a solid (metals, semiconductors or insulators) or in an electrolyte solution. 
B) 
A) 
Chapter 1 
 
 
22 
Mechanical properties 
The carbon-carbon chemical bond is one of the strongest chemical bonds in 
nature. Thus, it is not surprising that CNMs present excellent mechanical 
properties. 
Young’s modulus, an indicative for the stiffness of a solid material, has been 
measured in CNTs and graphene.35 These measurements revealed a higher 
strength and flexibility for SWCNTs than for MWCNTs and proved monolayer 
graphene as one of the strongest materials. 
Additional measurements have demonstrated that increasing the number of 
stacked layers of graphene, strength decreases.36 Moreover, theoretical studies 
suggest that under tensile loads, graphene begins to break at the outmost 
carbon atomic layers.37 
Optical properties 
In general, carbon materials are a black soot, as graphite. However, when the 
thickness of the film is smaller than the wavelength of light, light is transmitted 
with a minimum of absorbance. For instance, monolayer graphene presents a 
transmittance of 97.5 %.38 However, transparency of graphene decreases from 
monolayer to few-layer graphene.39 Related to CNTs, films with a thickness 
smaller than 50 nm are also transparent.40 
1.1.4. Applications 
Thanks to these electronic, mechanical and optical properties, CNTs and 
graphene can be used in a wide range of different applications. These materials 
are generally called “the materials of the future” and a whole technological 
revolution is happening with the objective of using them in real applications 
during the following years. 
Composites 
Excellent mechanical properties of CNTs and graphene make them great 
candidates as reinforcement components for composite materials. Both 
materials have been used in polymer-based and ceramic-based composites.41 As 
an example of the real applicability of these composites, it is worth mentioning 
that tennis racquets based on graphene/carbon fibre composites and ultra-light 
bicycles based on CNTs composites are already commercially available. 
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Electronics and optoelectronics 
Due to their electronic and optical properties, sp2-hybridized CNMs are a 
potential successor to other semiconductor materials used in electronics and 
optoelectronics, as silicon.42 
Semiconducting CNTs are promising channel materials in field-effect transistors 
(FETs). Flexible FETs containing a SWCNTs thin film have been developed (Figure 
15), with great response.43 On the other hand, the use of graphene for FET 
application remains a challenge, since graphene presents a zero band gap and 
semiconductivity is required for FETs. Research has focused on the opening of 
graphene band gap, which can be achieved through quantum confinement in 
narrow graphene nanoribbons (GNRs) or by doping graphene.44 
 
Figure 15. Flexible SWCNTs integrated circuit on plastic. A) Photograph. B) SEM image 
showing SWCNTs. Adapted from Cao et al. 2008.
43 
Radio frequency analog circuits can be significantly improved with the use of 
CNMs. Fully functional proof-of-concept CNTs circuits have been used as a 
demodulator for radio frequency signals.45 This application does not require an 
on/off behavior, thus semiconductivity is not necessary. For this reason, 
graphene is best suited for radio frequency electronics than for FET applications. 
Hence, using monolayer graphene, radio frequency devices that show low 
resistance, extrinsic and intrinsic current gain cut-off frequency, and maximum 
frequency of oscillation of 550 MHz have been fabricated.46 
Due to the transparency of monolayer graphene and CNTs thin films, they are 
suitable as transparent conductor in flexible organic light-emitting diodes 
(OLEDs). Traditionally, indium tin oxide (ITO) has been used. However, although 
CNMs do not significantly improve transparency of ITO, graphene and CNTs 
films are being incorporated since they introduce higher flexibility and 
mechanical resistance.47 
B) A) 
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Nevertheless, the main optoelectronic application for graphene is as component 
in touchpad screens, due to its flexibility and transparency. CVD-grown 
graphene with superior transparency and resistance than ITO has been 
successfully incorporated in fully functional touch-screen panel devices (Figure 
16).48 
 
 
Figure 16. Graphene-based touch-screen. A) Schematic representation. Adapted from 
Bonaccorso et al. 2010.
47a
 B) Flexible graphene-based touch panel. C) Functional 
graphene-based touchpad connected to a computer controller. Adapted from Bae et al. 
2010.
48 
Photovoltaic applications 
Transparent graphene and CNT films have attracted increasing interest in the 
photovoltaic field. Both graphene and CNTs have been used as photoactive 
elements in solar cells.49 However, further research in this field is needed before 
using CNTs and graphene in real applications.47a 
Energy storage 
Thinner electronic devices are emerging every day. Thus, the development of 
ultrathin batteries and capacitors is an important issue. Due to the high surface 
area of graphene and CNTs, combined with their excellent electronic properties, 
they can be used in the construction of ultrathin energy devices.50 For instance, 
a MWCNTs/cellulose nanocomposite has been used in both supercapacitor and 
Li-ion battery. The built thin-film structure allowed good electrochemical 
A) 
B) C) 
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performance, the ability to work on large ranges of mechanical deformation and 
compatibility with a wide variety of electrolytes.51 
Graphene has also showed great applicability within this field. For example, 
monolayer graphene obtained by CVD growth in Cu has been successfully used 
as rechargeable flexible battery, which is able to power a light emitting diode 
(LED) device (Figure 17).52 
 
Figure 17. A) Flexible graphene battery. B) LED powered by graphene battery. Adapted 
from Wei et al. 2013.
52
 
Biological applications 
CNTs and graphene have attracted much attention for their potential use in 
biology and nanomedicine. For this reason, the study of their biocompability has 
gained relevance. For instance, CNTs have shown toxicity, which is attributed to 
their physicochemical properties (including structure, length and aspect ratio, 
surface area, degree of aggregation, extent of oxidation, surface topology, 
manufacturing method or concentration). However, it is generally accepted that 
functionalized CNTs are less toxic. By attaching different water-soluble 
functional moieties, functionalized CNTs result in soluble materials that are 
further derivatized with active molecules, making them compatible with 
biological systems.53 In contrast, due to differences in production 
methodologies, particle morphology, and surface chemistry, biocompatibility of 
graphene derivatives highly depends on their production method used. For this 
reason, it is difficult to extract a general conclusion about the toxicity of 
graphene derivatives. Future research is still necessary to explore the biological 
response of the different graphene derivatives, taking into consideration their 
different physicochemical properties.54  
Tissue engineering is an emerging area that could be highly benefited from the 
use of nanomaterials. Hydrogels based on GO have been used as scaffolds for 
B) A) 
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cell proliferation for up to 7 days, showing biocompatibility and low toxicity.55 
Nevertheless, CNTs are the most promising material in this field. 3D MWCNTs 
scaffolds have been used to guide the in vitro formation of neural webs, 
achieving the spontaneous regrowth of neurite bundles into a dense random 
net. Moreover, the neuronal reconnection was demonstrated by simultaneous 
recordings of ventral local field potentials (LFPs) performed from two cocultured 
spinal slices (Figure 18).56 
 
  
Figure 18. LFPs recording in spinal slices in control sample (top) and sample with 3D 
MWCNTs scaffolds (3D CNF, bottom). Different LFPs are recorded in right and left slices 
in control sample, while both left and right slices recorded the same LFP in sample with 
3D CNF. Adapted from Usmani et al. 2016.
56
 
Besides, CNTs can cross the cell membrane.57 Therefore, another biomedical 
application for CNTs is drug delivery. Using linked CNTs to fluorescent labels, the 
suggested mechanism for internalization of CNTs was endocytic uptake. For 
drug delivery, a release of the drug is required after the CNTs penetrate the cell 
membrane. Drug release can be achieved by breaking the chemical bond used 
to link drug to CNTs, as disulfide or ester bond.58 Moreover, another alternative 
offered by CNTs is the release of the drug from the inner cavity of the tube 
(Figure 19).59 Controlled release of drugs has also been achieved after 
internalization in the cell with GO.60 For instance, GO was successfully used for 
gene delivery, releasing DNA in the cells by the breaking of sulfide bonds.61 
Introduction 
 
 
27 
 
Figure 19. TEM images of filled CNTs with carboplatin after incubation in cell culture 
medium for A) 30 min, B) 24 h. Adapted from Hampel et al. 2008.
59
 
Sensing applications 
A chemical sensor is a device which possesses a receptor which transforms 
physical, chemical or biochemical information into an energy form that can be 
measured. CNTs and graphene present high superficial area and excellent 
electronic and optical properties, thereby they can be incorporated in electrical, 
electrochemical and optical sensors.1 
The use of CNTs in electrochemical sensors for the detection of gas molecules 
has been widely extended. Many examples can be found in the literature as the 
detection of NH3, NO2, water or alcohol vapors.
62 Improved results were 
obtained when CNTs were decorated with metal NPs for the detection of H2, 
CH4, CO, and H2S.
63 
As with CNTs, electrochemical sensing has been achieved with graphene since 
the electrical conductivity of graphene is strongly modulated by adsorbates.42 
For instance, 3D graphene foam networks have been used for the detection of 
NH3 and NO2 (Figure 20).
64 The use of a 3D foam increased the area of 
adsorption for the gas. In addition, different electrochemical sensors based on 
graphene and graphene derivatives (GO and rGO) have also been produced for 
the detection of ions or other chemical species.65 
A) B) 
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Figure 20. A) Photograph of porous graphene foam. B) Change on the electrical 
resistance of graphene foam when NH3 is introduced and evacuated. Adapted from 
Yavari et al. 2011.
64
 
Graphene and CNTs are also perfect candidates for one of the most interesting 
sensing protocols: biosensing. A general introduction of biosensors and CNMs-
based biosensors is provided in next section. 
A) B) 
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1.2. Biosensors 
A biosensor is defined as a chemical sensor in which the recognition system uses 
a biochemical mechanism.66 This biological recognition system translates the 
information (analyte concentration) from the biochemical domain into a 
chemical or physical output signal. The terms receptor or bioreceptor are often 
used for the recognition system. The second key element of the sensing 
platform is the transducer, which converts chemical information into a 
measurable signal, for example emission of light or electron transfer reactions. 
Biosensors are self-contained systems, in which bioreceptor and transducer 
must be in direct spatial contact (Figure 21). 
 
Figure 21. Schematic representation of a general biosensor, defining the receptor and 
transducer parts. 
The main required properties for any biosensor are specificity and sensitivity. 
Specificity, related with the discrimination of other species different than the 
desired analyte, depends exclusively on the binding capabilities of the 
bioreceptor. On the other hand, sensitivity, defined as the ratio between the 
change in signal with respect to a change in concentration (i.e. the slope of the 
calibration curve), depends on both the bioreceptor and the transducer. 
Therefore, good specificity and sensitivity allow the applicability of biosensors in 
large varieties of samples, including body fluids, food samples or cell cultures. In 
addition, two important concepts to characterize the response of a biosensor 
are limit of detection (LOD) and limit of quantification (LOQ), defined as the 
minimal concentration of analyte that is required for its detection or 
quantification, respectively. LOD and LOQ are related with the blank, the noise-
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to-signal ratio and the sensitivity.66 LOD and LOQ are calculated by adding to the 
mean of the control signal 3 and 10 times the standard deviation, respectively. 
Biosensors can be classified according to the nature of the different parts: 
bioreceptor, transducer or produced signal.  
1.2.1. Immunosensors 
A possible classification of biosensors is according to the type of bioreceptor.67 
These bioreceptors are used because of their high specificity towards the 
analyte. Some important used bioreceptors are: 
 Enzymes. They are used because of their catalytic activity. The analyte 
can act as reagent in the biocatalyzed reaction or as inhibitor of the enzyme. 
 Antibodies. They are proteins that exhibit very specific binding 
capabilities for specific structures, denoted antigen. This kind of biosensors 
usually present extremely high specificity. Biosensors based on this 
antibody/antigen interaction are called immunosensors. 
 Nucleic acids. Deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) 
bind between each other and themselves, providing great potential for 
biosensing. 
 Aptamers. They are small synthetic oligonucleotides or peptides that 
bind to a specific target molecule. Biosensors based on aptamers are called 
aptasensors. 
 Cells and cell structures. The whole microorganism or organelles can be 
used as recognition element. 
Immunosensors present the main advantage of presenting the intrinsic 
sensitivity and specificity of the antibody/antigen interaction. Antibodies 
generally consist of four polypeptides: two identical heavy chains and two 
identical light chains joined by disulfide bonds to form a Y-shaped protein 
(Figure 22). Each chain presents a constant and a variable region. The variable 
region corresponds with the amino-terminated end of the chain and gives the 
antibody the specific site for binding the antigen.68 The higher is the affinity 
shown by the antibody for the antigen, the better is the sensitivity reached.69 In 
most immunosensors, one of the immunoreagents (antigen or antibody) is 
immobilized on a solid support, and the interaction takes place in a solid-liquid 
interface. Several strategies can be used for the immobilization of antibodies, 
including covalent attachment, physical adsorption or cross-linking.70 As 
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compared to physical adsorption, covalent attachment allows control over the 
orientation of the immobilized antibodies. 
 
Figure 22. Schematic representation of antibodies structure, composed by two heavy 
and two light chains. Each chain is divided in its variable and constant regions. 
Different immunosensor strategies are applied. The most commonly used are 
summarized below (Figure 23):71 
 Direct assay. This approach is performed by simply incubating the 
antigen with excess of the antibody. The antigen naturally creates a detectable 
signal. In this case, sensitivity depends on the amount of antibody and the 
intensity of signal is proportional to the concentration of antigen. 
 Competitive assay. The antigen to be detected (analyte) does not create 
a detectable signal by itself. The analyte is previously mixed with a known 
concentration of a different labeled antigen. An excess of this mixture is 
incubated with the antibody, which competes between binding to the analyte 
and the labeled antigen. Thereby, the concentration of analyte is inversely 
proportional to the intensity of the signal produced by the labeled antigen. 
 Sandwich assay. Antigen is incubated with an excess of an immobilized 
antibody, called capture antibody. Then, the formed antibody/antigen complex 
is incubated with a second labeled antibody, which binds to a different specific 
site of the antigen. The excess of this labeled antibody is removed. 
Consequently, intensity of signal obtained is proportional to the concentration 
of antigen. The main advantage of this method is that specificity is highly 
increased by using two antigen/antibody recognitions, while sensitivity depends 
on the amount of capture antibody present. 
Chapter 1 
 
 
32 
 
Figure 23. Different immunosensing protocols. A) Direct immunoassay. B) Competitive 
immunoassay. C) Sandwich immunoassay. 
At this point, it is worth to mention that not any analytical device which uses 
immunoreagents can be considered as an immunosensor.69 Thereby, a device 
should be considered as an immunosensor when it fits into the definition given 
for the wider concept of biosensors. For instance, as previously mentioned, a 
biosensor is a self-contained system, in which bioreceptor and transducer must 
be in direct spatial contact. As an example, this definition excludes the known 
enzyme-linked immunosorbent assay (ELISA), where the label of the second 
antibody is an enzyme, which catalyzes a reaction, producing a detectable 
product. However, the detection of this product takes place in a separated 
device. 
1.2.2. Electrochemiluminescence 
A different classification for biosensors is based on the signal that is produced as 
consequence of the detection of the analyte. 
Although electrochemical or acoustic methods are also applied, optical 
detection is the most applied method in immunosensors.69 The main advantage 
of optical detection is the simplicity of the measurements. Different optical 
methods are the measurement of absorbance, fluorescence or luminescence. 
The last one presents the benefit that it does not require a source of light, which 
can improve significantly the sensitivity.72 
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Different luminescence methods used in biosensors are chemiluminescence, 
bioluminescence, thermoluminescence or electrochemiluminescence (ECL). 
Among them, ECL involves the generation of species at an electrode surface that 
undergo electron-transfer reactions to form excited states that produce light.73  
Several chemical species, such as luminol or perylene bisimide derivatives, are 
known to be ECL luminophores. Among them, the most commonly used are the 
derivatives of tris(bipyridine)ruthenium complexes, [Ru(bpy)3]
2+. Generally, a co-
reactant is used in ECL reactions. The co-reactant is the specie that is directly 
oxidized or reduced by the electrode, creating a strong reducing or oxidizing 
intermediate that reacts with the ECL luminophore, generating the light-
emitting excited state. Tripropylamine (TPA) is the most commonly used co-
reactant of Ru complexes, since the [Ru(bpy)3]
2+/TPA system presents the 
highest ECL efficiency.74 
The mechanism of ECL production by the [Ru(bpy)3]
2+/TPA system has been 
extensively studied and different possible paths are described, including the 
direct oxidation of TPA, [Ru(bpy)3]
2+ or both species on the surface of the 
electrode.75 Nevertheless, in the case of a sandwich immunoassay, TPA is the 
only free specie in the system, since [Ru(bpy)3]
2+ is attached to the antibody. For 
this reason, the typically accepted mechanism in this kind of biosensors involves 
the oxidation TPA, which, in turn excites the [Ru(bpy)3]
2+. The direct oxidation of 
[Ru(bpy)3]
2+ is very unlikely because of its large distance from the electrode 
surface, as predicted by Marcus theory. Therefore, we suggest the mechanism 
that is displayed below in a simplified way. 
TPA  TPA•+ + e- 
TPA•+  TPA• + H+ 
TPA• + [Ru(bpy)3]
2+  [Ru(bpy)3]
+ + products 
[Ru(bpy)3]
+ + TPA•+  [Ru(bpy)3]
2+* + products 
[Ru(bpy)3]
2+*  [Ru(bpy)3]
2+ + h (610 nm) 
In summary, TPA is oxidized on the electrode surface to the corresponding 
radical cation, TPA•+, which losses a proton. The created radical reduces 
[Ru(bpy)3]
2+ to [Ru(bpy)3]
+, which reacts with TPA•+, generating the ruthenium 
complex in its excited state, [Ru(bpy)3]
2+*. The energetic decay from the excited 
state to the ground state results in emission of light at 610 nm (Figure 24). 
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Figure 24. Schematic representation of the suggested mechanism for ECL production by 
the [Ru(bpy)3]
2+
/TPA system. 
The great advantage of ECL-based biosensors is the combination of the 
advantages of both luminescent and electrochemical sensors. On one hand, 
luminescence techniques do not require a source of light, reducing the 
background signal. On the other hand, electrochemistry methods provide good 
selectivity by selecting the specific potential for the measurements. However, 
the main disadvantage is the requirement of labeling the second antibody. 
Labeling probes inevitably alters their functional properties and there is the 
possibility that even in one single experiment, not every probe is labeled with 
the same number of tags.76 Therefore, the use of label-free biosensors that 
measure the inherent properties of the probe, the target, or the probe-target 
complex can overcome this drawback. Many label-free biosensors based on 
acoustic, electrical, mechanical, magnetic, and optical techniques have been 
developed.77 Regarding immunosensors, the label-free devices have some 
advantages in comparison with the sandwich-type. For instance, they could be 
used to directly monitor the antibody-antigen binding process and they remove 
the experimental uncertainty induced by the effect of the label, as the 
conservation of the molecular conformation or the blocking of active binding 
site. 
1.2.3. CNMs-based biosensors 
The last classification for biosensors is based on the transducer, which converts 
the response of the receptor into a signal. Due to their high surface area and 
their electrical and optical properties, CNTs and graphene have been exploited 
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for the development of large number of CNTs-based and graphene-based 
biosensors. 
CNTs-based biosensors 
CNTs have been extensively used for different biosensing applications. Their 
large surface-to-volume ratio and their high capacity to mediate fast electron-
transfer kinetics are the two main advantages they present compared to 
traditional sensors. 
Metal electrodes (Au, Pt, etc.) and glassy carbon electrode (GCE) were the most 
commonly used electrodes before applying NMs. Some disadvantages of these 
electrodes are poor sensitivity and stability, low reproducibility and large 
response times. The combination of typical electrodes with CNTs can improve 
these disadvantages due to their optimal properties as electrodes.78 For 
instance, CNTs have demonstrated excellent electrocatalytic properties towards 
electroactive species as phenolic compounds, tryptophan, hydrogen peroxide, 
dopamine, ascorbic acid and uric acid.79 
Moreover, functionalization of CNTs allows to introduce new desired properties, 
as solubility or biocompatibility,80 while good electrochemical behavior is 
maintained.81 In addition, functionalization permits to link biomolecules, which 
makes them great candidates for different types of biosensors.82 In particular, 
combining the ability of CNTs for behaving as electrodes with their capacity for 
being functionalized, has extended their use in electrochemical biosensors. For 
example, Raicopol et al. developed an amperometric glucose biosensor 
combining the electrocatalytic activity of CNTs towards the reduction of H2O2 
with the possibility of functionalizing the tubes with Glucose oxidase (GOx).83 
The detection of glucose was achieved by the electrochemical detection of H2O2, 
byproduct of the enzymatic degradation of glucose with GOx. Another example 
of electrochemical biosensor based on CNTs was presented by Miodek et al. for 
the detection of human cellular prion, which is a group of proteins responsible 
for transmissible spongiform encephalopathy.84 They used functionalized 
MWCNTs with polyamidoamine (PAMAM) dendrons, with ferrocenyl redox 
marker as linker between dendrons and DNA aptamer. The interaction between 
aptamer and protein led to variations of the electrochemical signal produced by 
ferrocenyl group. On the other hand, ECL biosensors can also use electrodes 
modified with CNTs. For instance, detection of glucose was achieved by Lin et al. 
using GCE modified with MWCNTs-Nafion film functionalized with GOx.85 
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Reaction of glucose with GOx produced H2O2, coreactant of luminol in ECL 
production. 
Immunoassays based on ECL are a powerful biosensing tool, as previously 
mentioned. As a prime example, covalently difunctionalized MWCNTs were 
used by Zamolo et al. for the detection of marine toxin palytoxin, following this 
approach. Difunctionalization of CNTs allowed both the covalent immobilization 
of the tube on the electrode surface and the linking of primary antibody to the 
tube (Figure 25). 86 
 
Figure 25. ECL immunosensor based on the difunctionalization of MWCNTs. Adapted 
from Zamolo et al. 2013.
 86
 
Prostate cancer biomarkers have been detected by ECL immunoassay using 
CNTs. As an example, Sardesai et al. reported the use of silica NPs containing 
[Ru(bpy)3]
2+ and two different secondary antibodies for the simultaneous 
detection of prostate-specific antigen (PSA) and interleukin-6 (IL-6).87 They used 
functionalized SWCNTs forests with primary antibodies for the capture of the 
corresponding antigen. They guarantee simultaneous detection in a single 
sample without cross-contamination, by separating SWCNTs functionalized with 
anti-PSA antibodies from SWCNTs functionalized with anti-IL-6 antibodies in 
different microwells (Figure 26). In this way, they achieved good LOD for each 
analyzed protein (1 pg/mL for PSA and 0.25 pg/mL for IL-6). By following this 
approach, the same research group developed an automated immunoarray for 
simultaneous detection of four prostate cancer biomarkers: PSA, IL-6, prostate-
specific membrane antigen (PSMA) and platelet factor-4 (PF-4).88 
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Figure 26. Simultaneous detection of two prostate cancer biomarkers using separated 
microwells containing SWCNTs forests and silica nanoparticles containing [Ru(bpy)3]
2+
. 
Adapted from Sardesai et al. 2011.
87
 
Graphene-based biosensors 
Graphene, as well as CNTs, presents electrical and optical properties desired for 
biosensing protocols. However, when compared to CNTs, the structural 
differences will play an important role in the design of the biosensor. In 
addition, CNTs are grown from metallic NPs, that are difficult to completely 
remove, affecting the behavior of the biosensor, while graphene is usually 
obtained by cleaner methods.89 Depending on production method for graphene, 
different derivatives, as GO or rGO, can be obtained. These graphene derivatives 
present varying amounts of defects. Nevertheless, the presence of defects is not 
always a disadvantage for biosensing applications, since it is well known that 
heterogeneous electron-transfer in the electrochemistry of sp2 carbon atoms 
occurs at the edges and defects.90 
Graphene is an excellent conductor of electrical charge. For this reason, it can 
be applied in electrochemical biosensors. For instance, graphene has been used 
in many electrochemical approaches for sensing glucose. Most of these 
approaches are based on the electrochemical detection of hydrogen peroxide 
produced by GOx, which is usually linked to the graphene derivative.89 In 
addition, some approaches, as the use of N-doped graphene or the introduction 
of Au NPs, have improved the methodology.91 
Graphene derivatives are also used in fluorescence biosensors, particularly GO. 
Fluorescence can be effectively quenched by GO through a fluorescence 
resonance energy transfer (FRET) mechanism, in which energy is transferred 
from a donor to an acceptor dye molecule. Moreover, single-stranded DNA 
(ssDNA) can non-covalently bind GO, while double-stranded DNA (dsDNA) 
cannot. In this context, high number of biosensors for the detection of DNA 
have been reported, in which ssDNA linked to a fluorescent dye was bound to 
Chapter 1 
 
 
38 
GO, with consequent fluorescent quenching. When target complementary 
ssDNA was added, dsDNA complex was formed and unbound from GO, thus 
fluorescence of the dye was observed (Figure 27).92 This approach has been 
extended to the detection of RNA and mismatches in DNA.93 
 
Figure 27. Biosensor for ssDNA detection based on FRET quenching induced by GO. 
Adapted from Lu et al. 2009.
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ECL protocols are improved by using graphene derivatives, which can be 
employed as matrix for the immobilization on the electrode of capture probe, 
detection probe or both.94 For instance, Gao et al. developed a biosensor for the 
detection of ethanol using GO as both decorating agent for immobilization of 
[Ru(bpy)3]
2+ and matrix to immobilize bovine serum albumina (BSA). Alcohol 
dehydrogenase (ADH) was immobilized on BSA. Therefore, ADH produced NADH 
in presence of ethanol. The generated NADH was co-reactant with [Ru(bpy)3]
2+ 
on ECL production.95 Similarly, an ECL-based immunoassay for the detection of 
prostate cancer biomarker PSA was developed by Wu et al. using rGO as matrix 
for immobilization of both capture antibody and ECL source. Au-Ag NPs were 
deposited on rGO surface, and they served as anchor point for capture antibody 
and graphene quantum dots (GQDs), as shown on Figure 28. Based on a direct 
immunoassay, a decrease of ECL intensity of the GQDs was recorded when PSA 
bound to antibody. Consequently, concentration of PSA was inversely 
proportional to ECL intensity. 96  
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Figure 28. ECL-based immunosensor for PSA detection, using rGO as immobilization 
matrix for capture antibodies and electrochemiluminescent GQDs. Adapted from Wu et 
al. 2016.
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Chapter 2 
Double functionalization of 
carbon nanotubes 
 
2.1. Introduction: CNTs functionalization 
Studies about searching for alternatives to sonication for solubilizing CNTs gave 
rise to the study of their functionalization, in other words, the modification of 
their surface.1 However, the large number of different functionalization 
methods allowed the use of CNTs functionalization in many applications, other 
than solubility, as mechanical, electrical or biomedical applications.2 
The different approaches for functionalization of CNTs can be classified in three 
different groups: Non-covalent adsoprtion; endohedral filling of empty cavity 
inside; and covalent attachment onto the tube walls through chemical reaction.1 
2.1.1. Non-covalent adsorption 
Non-covalent functionalization of CNTs has been extensively studied because it 
presents the main advantage of not affecting the electronic network of the 
tube. This modification method is based on non-covalent interactions as Van der 
Waals forces or π-π stacking. Aqueous suspensions of individual CNTs by using a 
surfactant, sodium dodecyl sulfate (SDS), was the first example of non-covalent 
modification.3 Many anionic, cationic and nonionic surfactants have been used 
to modify CNTs, as sodium dodecylbenzene sulfonate (SDBS), Triton X, Tween or 
Pluronic, among others (Figure 1A).4 
The main drawback for the use of surfactants is that surfactant molecules on the 
surface of CNTs are in dynamic equilibrium with molecules in bulk solution, 
which makes them easy to remove.5 The use of polymers wrapped on CNTs can 
overcome this disadvantage (Figure 1B). Wrapping of CNTs has been described 
for different types of polymers, as π-conjugated,6 aromatic,7 non-aromatic,8 
cationic,9 or block polymers.10 
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Pyrene and pyrene derivatives are known to irreversibly bind CNTs walls 
through π-stacking (Figure 1C).11 Several applications have taken advantage 
from this fact.12 Moreover, this kind of functionalization has been extended to 
other polycyclic aromatic hydrocarbons as anthracene or naphthalene.13 
These π-π interactions have also allowed the non-covalent binding of 
biomolecules to CNTs. There are many examples in the literature with different 
biomolecules, including proteins (as streptavidin, cytochrome c or antibodies),14 
enzymes,15 oligonucleotides16 or DNA (Figure 1D).17 
 
Figure 1. Non-covalent functionalization of CNTs with A) surfactants,
4a
 B) polymers,
8b
 C) 
pyrene derivatives,
11
 and D) DNA.
17a
 
2.1.2. Endohedral filling 
The empty inner cavity of CNTs has been exploited to the functionalization with 
different substances.1 Due to their diameter, the uptake of liquids inside CNTs 
by capillarity was first predicted in 1992.18 It was demonstrated soon with liquid 
lead (Figure 2A),19 and after that, many other species were introduced inside the 
tubes by this process, as metals, metal oxides or water (Figure 2B).20 In addition, 
many examples can be found in the literature of inner functionalization of CNTs 
with different substances as organic molecules (Figure 2C) or other carbon 
forms as fullerenes or graphene nanoribbons.21 
D) C) 
B) A) 
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Figure 2. Filled CNTs. TEM images of CNTs filled with A) lead
19
 and B) aqueous 
solution.
20c
 C) Schematic representation of CNT filled with β-carotene.
21a
 
2.1.3. Covalent attachment 
This functionalization is based on the covalent linking of functional groups to the 
outer wall of CNTs. It happens by a change on carbon hybridization from sp2 to 
sp3, with the consequent loss of the local conjugation.2 On the one hand, by the 
formation of a covalent bond, this kind of modifications generally present a high 
stability. On the other hand, the loss of sp2 conjugation affects the electronic 
properties. 
One of the first successful covalent functionalization of CNTs was fluorination 
(Figure 3).22 The main advantage of this method was to create starting points for 
new modifications (Figure 3): the treatment with anhydrous hydrazine removed 
fluorine atoms, regenerating pristine CNTs structure;22 the reaction with 
Grignard compounds or alkyllithium led to the alkylation of the tubes;23 and 
Diels-Alder cycloadditions were performed with several dienes.24 
 
Figure 3. Fluorination of CNTs and reactions of fluorinated CNTs. 
B) C) 
A) 
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Similarly, functionalization of CNTs with carboxylic groups introduced by 
oxidation with acids25 allows a further modification by formation of amide26 or 
ester27 bonds when making carboxylic groups react with amines or alcohols. It is 
worth noting that amidation and esterification of carboxylic groups of CNTs is 
one of the most exploited functionalization techniques. However, the harsh 
conditions required for the oxidation generally introduce large amounts of 
defects. 
As consequence of the extended π conjugation on CNTs walls, they undergo 
different cycloadditions and there are many examples in the literature (Figure 
4). Carbene [2+1] cycloadditions were the first one to be described.26a Carbenes 
are also known to produce nucleofilic additions.28 Other [2+1] cycloadditions 
that have been performed on CNTs are the Bingel reaction29 and nitrene 
cycloadditions.28 In addition, [4+2] Diels-Alder cycloadditions have also been 
described, using in-situ-generated o-quinodimethanes.30 Another interesting 
[4+2] cycloaddition is the 1,3-dipolar cycloaddition of azomethine ylides 
generated in situ by thermal condensation of an α-aminoacid and an aldehyde. 
This well-known reaction in the chemistry of fullerenes, was first performed on 
CNTs by the group of Professor Maurizio Prato.31 
 
Figure 4. Cycloaddition reactions. A) Carbene [2+1], B) Bingel reaction, C) Nitrene [2+1], 
D) 1,3-dipolar cycloaddition, E) Diels-Alder. 
Another described covalent functionalization is based on the generation of 
carbanions on the tube walls when treating CNTs with sec-butyllithium. In this 
way, polymers can be directly grown covalently linked to the tube walls after 
formation of carbanions, inducing anionic polymerization.32 Moreover, creation 
of carbanions on the tube can also be used to introduce carboxylic groups, in 
the presence of CO2.
33 
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Addition of radicals to CNTs was predicted with simulations by Ni et al. and 
experimentally exploited by several research studies (Figure 5).34 Some 
examples of radical additions have been carried out with known radical 
precursors, for example: perfluorinated alkyl iodides,28 peroxides or xanthates.35 
 
Figure 5. Radical addition reactions on CNTs with A) perfluorinated alkyl oxides, B) 
peroxides and C) xanthates. 
However, one of the most used covalent attachment on CNTs is the arylation. 
This radical addition was discovered and extensively studied by the group of 
James M. Tour.36 Firstly, they performed this covalent modification by 
electrochemical reduction of aryldiazonium salts, but the thermal 
decomposition of aryldiazionioum salts generated in situ from corresponding 
anilines with isopentyl nitrite was demonstrated as the best approach and 
became the most used (Figure 6).37 This chemical modification of CNTs has also 
been performed using water as solvent or solvent-free.38 
 
Figure 6. Aryldiazonium reaction. A) Electrochemical reduction of aryldiazonium salt. B) 
Thermal decomposition of aryldiazionium compound generated in situ. 
The mechanism of the reaction involves the reaction of the aryldiazonium with 
hydroxide, producing a diazotate (Figure 7A).39 The diazotate reacts with 
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another aryldiazonium, leading to the formation of a diazoanhydride, which 
decomposes releasing N2 and producing an aryl radical. Then, the corresponding 
aryl radical reacts with the CNT, creating an arene-CNT-radical intermediate that 
links with another radical (Figure 7B). This second coupling can happen in 
adjacent positions or in a different position after delocalization of the radical. 
 
Figure 7. Mechanism of aryldiazionium radical addition. A) Aryl radical formation from 
diazonium compound. B) Radical addition to CNTs. 
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2.2. Aim of the work 
The use of carbon nanotubes for biosensing applications has been 
demonstrated along the previous introduction. Moreover, their 
functionalization is a powerful tool for tuning their properties. 
In this chapter, covalent functionalization of double-walled carbon nanotubes 
(DWCNTs) for the development of an electrochemiluminescent immunosensor 
for prostate cancer detection is reported. This chapter is focused on the 
description of the chemical modification of the tubes towards obtaining a final 
material for its use on the biosensor device. Biosensor assembly and results 
obtained will be reported in another chapter. 
The desired final material must accomplish two main requirements: to allow the 
specifically linkage with the corresponding antibody and, on the other hand, to 
afford a very stable attachment on the electrode surface. The adopted strategy 
for achieving this goal was the difunctionalization,40 where the walls of the 
tubes were modified with two different moieties, carrying two different 
protecting groups of amines.  
Previous experience of our research group has demonstrated that arylation of 
CNTs through diazonium salt formation is a successful method for the 
introduction of orthogonal protecting groups.41 Due to the presence of these 
orthogonal groups, the selective deprotection of amino groups allowed a 
sequence of reactions that afforded DWCNTs with maleimidic terminal groups 
for the attachment of the antibody through thiol groups present in the 
antibody, as well as primary amino groups for anchoring the modified CNT on 
the previously modified surface of the electrode (Figure 8). 
 
Figure 8. Difunctional DWCNTs with maleimidic function for attachment of antibody and 
free amino groups for anchoring on electrode. The thiol group is arbitrary represented 
at the constant domain of the heavy chain of the antibody. 
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2.3. Results and discussion 
In this section, the difunctionalization of DWCNTs by radical addition of two aryl 
moieties will be described. Two different approaches (sequential and one-pot 
reactions) will be compared. In addition, the modification of the introduced 
functional groups towards a biosensing device will be reported. In addition, the 
difunctionalization of oxidized MWCNTs (ox-MWCNTs) by two non-competitive 
reactions (aryl radical addition and amidation of carboxylic groups) will be 
described. 
Thermal decomposition of aryldiazionium species generated in situ from 
corresponding anilines has been proved as a useful tool for arylation of CNTs.37 
Thus, the first objective was to synthesize two anilines with differently 
protected amino groups, in order to perform the desired orthogonal 
difunctionalization. The selected protecting groups were tert-butyloxycarbonyl 
(Boc) and phthalimide, because each one is compatible under the deprotection 
conditions of the other one, and both are stable under the reaction conditions 
for arylation.42 In addition, a short-oxygenated alkyl chain would increase CNTs 
solubility in water, which is an important requirement for the linking of the 
antibody. 
The synthesis of aniline 9 and aniline 11 is shown on Figure 9 and is fully 
described in the section dedicated to experimental details. In summary, anilines 
were obtained by reduction of the corresponding nitro benzyl compounds 8 and 
10, produced by the amidation of 4-nitrobenzoyl chloride with monoprotected 
diamines 3 and 5, which were synthesized following literature procedures.43 
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Figure 9. Synthesis of desired anilines A) 9, and B) 11. 
2.3.1. Sequential difunctionalization of DWCNTs 
The first approach for the difunctionalization of DWCNTs with the two phenyl 
radicals carrying differently protected amino groups was to introduce each 
moiety in a differentiated synthetic step. In a first reaction, arylation with 9 was 
carried out. Then, after working up the reaction and characterizing the resulting 
product, a second functionalization was performed, where the aryl radical 
generated from aniline 11 reacted with the functionalized tubes DWCNTs 1 
(Figure 10). 
 
Figure 10. Sequential arylation of DWCNTs. 
Chapter 2 
 
 
54 
In these reactions, aryldiazonium compounds are generated in situ by the 
reaction of the anilines with isopentyl nitrite (12). Aryldiazonium compounds 
decompose at 80 ºC into radical species that react with the tubes. Radicals are 
known to be unstable compounds with extremely high reactivity, so reactions 
with radical mechanisms usually generate large number of side products (Figure 
7, page 50). Thus, to avoid formation of side products, concentration of radical 
species must be much smaller than concentration of DWCNTs. For this reason, 
the addition of 12 (the reactant which led to the formation of the aryldiazonium 
compound, and consequently, the generation of radical species) was slowly 
performed and using a solution of 12 at low concentration. After the reaction, 
the crude was washed with large amounts of several organic solvents to remove 
the excess of reagents and possible side products. 
Success of the difunctionalization was firstly confirmed by Raman spectroscopy. 
As shown on normalized spectra on Figure 11A, the intensity ratio between D 
and G peaks (ID/IG) increased in each reaction. The ratio ID/IG increased from 
0.11 for pristine DWCNTs to 0.23 for DWCNTs 1, after first reaction, and to 0.33 
for DWCNTs 2, after second one. The increase of this ID/IG ratio is caused by an 
increase of defects in the CNTs structure. Therefore, the arylation successfully 
took place in both sequential functionalization steps, since covalent 
modifications of CNTs involve the change of sp2 carbon atoms into sp3.36 
Once the success of the arylation was confirmed by Raman spectroscopy, the 
functionalized CNTs were also characterized by TGA, a powerful technique for 
quantification of functionalization. The functionalization degree (FD) was 
calculated through Equation 1, where L corresponds to the weight loss observed 
at 500 ºC (in %), after correcting the weight loss of the pristine material. In the 
sequential functionalization, for the second step, L refers to the difference 
between first and second functionalization. The molecular weight (MW) is 
stablish for the expected desorbed moiety. The conversion factor (104) provides 
data in the desired unities (μmol /g). 
Equation 1                
        
         
   
TGA profiles showed on Figure 11B exhibit a quasi-flat line for pristine DWCNTs 
and a high drop in weight percentage between 150 ºC and 450 ºC for DWCNTs 1 
and 2, because the thermal degradation of introduced functional groups takes 
place at this temperature range. Thus, in this work, the temperature of 500 ºC 
has been chosen after analyzing the thermal stability of the corresponding aryl 
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groups in N2 atmosphere. The DWCNTs 1 showed a weight loss of 12.6 % at 500 
ºC, 10.4 % more than pristine DWCNTs at that temperature. In this manner, 
DWCNTs 1 showed a FD of 273 µmol/g by applying the Equation 1, considering a 
MW for the introduced functionality of 381 g/mol. Subsequently, the weight 
loss of DWCNTs 2 was 14.3 %, only 1.7 % more than DWCNTs 1, resulting in a FD 
of 48 µmol/g, which is a much lower value than in the first reaction. 
 
Figure 11. A) Raman spectra and B) TGA profiles of pristine DWCNTs (black), DWCNTs 1 
(red) and DWCNTs 2 (blue). 
The characterization results are summarized in Table 1. Both Raman and TGA 
results suggest a much higher functionalization for the reaction with aniline 9 
than with aniline 11. Probably, this is because of the coverage of the tube walls 
in first reaction is hindering the second reaction. 
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Table 1. Characterization summary. The intensity ratio between D and G peaks (ID/IG) in 
Raman spectroscopy is shown for the different DWCNTs. The functionalization degree is 
calculated with Equation 1 using the weight loss displayed in the table. 
Sample ID/IG 
Weight loss (%) 
at 500 ºC in TGA 
Functionalization 
degree (µmol/g) 
Pristine DWCNTs 0.11 2.2 - 
DWCNTs 1 0.23 10.4 273 
DWCNTs 2 0.33 12.6 48 
 
In order to obtain the desired material (Figure 8, page 51), maleimidic function 
must be introduced by amidic coupling after deprotection of one kind of the 
protected amino groups. As final step, the second protecting group must be 
removed, to have free amino groups available for attaching to the electrode. It 
is worth mentioning that the strategy followed involved removing phthalimide 
group before introducing maleimide, because maleimide is not stable under the 
conditions for removal of phthalimide group. 
The followed synthetic path is displayed in Figure 12. The first step was the 
removal of phthalimide group by using hydrazine monohydrate (N2H4·H2O). The 
deprotection was confirmed by Kaiser test (KT), affording a number of 73 µmol 
of free amines per gram of sample. Maleimidic function was then introduced by 
the reaction of the primary amines of DWCNTs 3 with the compound 13. The KT 
afforded a value of free amino groups of 35 µmol/g for DWCNTs 4. This 
decrease showed that deprotected amines reacted with compound 13, 
introducing maleimide group. Last step was the removal of Boc group, by acidic 
treatment with hydrochloric acid. However, in this case, KT result was 38 
µmol/g for DWCNTs 5, a slight increase compared to DWCNTs 4, meaning that a 
small amount of primary amino groups was obtained. 
This final result was in agreement with the previous assumption about the lower 
reactivity achieved in the second functionalization compared to the first one. 
For this reason, this material was discarded, since a higher number of amino 
groups is required to obtain a good coverage of the electrode with CNTs when 
assembling the biosensor. 
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Figure 12. Modification of DWCNTs towards desired final material 
2.3.2. One-pot difunctionalization of DWCNTs 
A good coverage of the electrode with CNTs and a high functionalization with 
antibody are equally important for our application, i.e. the same amount of both 
functional groups must be introduced. Functionalization of DWCNTs with each 
aniline in two different steps had led to a much higher first functionalization 
degree. Therefore, a different approach was necessary. 
One-pot double or triple functionalization of CNTs with aryldiazionium coupling 
has been reported,41 resulting only small differences in the reactivity between 
different aryl radicals. An additional advantage of this method is the reduction 
of total time, since it only involves one synthetic step. 
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Figure 13. One-pot difunctionalization of DWCNTs. 
Difunctionalization of DWCNTs was performed in one step, as shown in Figure 
13. The same molar amount was used for both anilines in DWCNTs dispersion. 
Similar to the sequential difunctionalization, the reaction was carried out with 
dropwise addition of 12 solved in NMP at low concentration at 80 ºC, and 
reaction was followed by copious washings with different solvents. 
The obtained DWCNTs 6 were characterized by Raman spectroscopy and TGA. 
Results of this characterization are presented in Figure 14 and summarized on 
Table 2. 
Raman spectroscopy showed an increment of D band intensity on normalized 
spectra after the reaction process, which confirmed the success of covalent 
functionalization. The ID/IG ratio increased from 0.11 for pristine DWCNTs to 
0.21 for DWCNTs 6. This value is comparable to the first functionalization at the 
sequential difunctionalization. 
TGA profile of DWCNTs 6 showed a high weight drop between 150 ºC and 450 
ºC, corresponding to the thermal degradation of the functional groups 
introduced. The weight loss at 500 ºC was 15.5 %, it means a 13.3 % more than 
weight loss for pristine DWCNTs. However, in this case, Equation 1 cannot be 
directly applied, since we have introduced two different moieties, with different 
molecular weights, in one step. In order to obtain a comparative FD, we assume 
equal contribution of 9 and 11 on the functionalization, in other words, half of 
the functionalization of DWCNTs is due to 9 and the other half is due to 11. With 
this assumption, using an averaged MW of 366 g/mol, we calculate an 
approximate FD of 280 µmol/g by applying Equation 1. 
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Figure 14. Characterization of DWCNTs 6 (green) by A) Raman spectroscopy and B) TGA. 
Table 2. Characterization results of DWCNTs 6. The intensity ratio between D and G 
peaks (ID/IG) in Raman spectroscopy is displayed. The functionalization degree is 
calculated with Equation 1 using the weight loss shown in the table. 
Sample ID/IG 
Weight loss (%) 
at 500 ºC in TGA 
Functionalization 
degree (µmol/g) 
Pristine DWCNTs 0.11 2.2 - 
DWCNTs 6 0.21 15.5 280 
 
Subsequently, a similar procedure to that for DWCNTs modified by sequential 
difunctionalization was followed for the modification of the introduced 
functional groups (Figure 15). Thus, the deprotection of phthalimide groups on 
DWCNTs 7 was performed and then confirmed by a KT value of 58 µmol/g. A 
decrease of the number of deprotected amino groups in DWCNTs 8 (KT value of 
33 µmol/g) verified the introduction of maleimidic function through amidic 
coupling on the free amines. Finally, the last step of Boc deprotection was 
performed for DWCNTs 9, affording a FD by KT of 57 µmol/g.  
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Figure 15. Modification of introduced functional groups of DWCNTs in one-pot 
difunctionalization. 
In contrast to the sequential difunctionalization, functionalization values 
obtained by KT were very similar when phthalimide and Boc groups were 
removed. These experimental results confirmed that by the addition of both 
phenyl groups generated from the corresponding anilines at the same step, we 
are introducing the same amount of each of them. The final material, DWCNTs 
9, contained both maleimidic functional groups and primary amines. In 
conclusion, DWCNTs 9 are good candidate for specifically linking the 
corresponding antibody 7E11c. This antibody was selected due to its high 
specificity towards PSMA, a known prostate cancer antigen. 
 
Figure 16. Covalent attachment of anti-PSMA antibody to DWCNTs. The thiol group is 
arbitrary represented at the constant domain of the heavy chain of the antibody. 
The covalent attachment of anti-PSMA antibody 7E11c was achieved by sulfur 
bond through maleimide group and the thiol groups previously introduced to 
the antibody (Figure 16).44 The antibodies were previously modified with thiol 
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groups (2 thiol groups per antibody) by our supplier. Thiol groups had been 
introduced by the addition of Traut’s reagent (2-iminothiolane) to the free 
amines of lysine aminoacid. This addition is not specific; therefore, any lysine 
can be functionalized with thiol groups. However, due to the small size of the 
antigen binding site in comparison with the whole antibody, there is high 
probability to derivatize the constant region of the antibody. After the reaction, 
the excess of antibody was washed away with phosphate buffer saline (PBS), by 
using centrifugations. The washings were monitored by measuring UV-Vis 
spectra (Figure 17A), in order to know that the unreacted antibody was 
removed. By this procedure, we can be sure that all antibodies present in 
sample DWCNTs 10, are covalently linked. However, we cannot confirm that the 
whole structure of the antibody is fully maintained after the reaction. It is highly 
probable that the antibody can be immobilized in different forms, fragments 
and structures, some of them probably retaining the same biorecognition 
capabilities as the native antibody. 
For the characterization of DWCNTs 10, TGA analysis was used. For this purpose, 
a small fraction of sample was dialyzed with Milli-Q water, in order to remove 
PBS salts. Then, after drying the sample, the TGA for DWCNTs 10 was performed 
(Figure 17B). A huge weight loss was observed, because of the thermal removal 
of specie with high MW. This experimental evidence confirmed the presence of 
the antibody on the carbon material. The weight loss measured at 500 ºC was 
23.7 %, a 7.8 % more than DWCNTs 9, which corresponds to a FD of 0.52 µmol 
of antibody per gram of sample. 
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Figure 17. A) UV-Vis absorption spectra of washing solutions of antibody attachment 
reactions.
i
 B) TGA curves of DWCNTs 9 (pink) and DWCNTs 10 (purple). 
2.3.3. Non-competitive functionalization of oxidized 
MWCNTs 
Although a good FD of anti-PSMA antibody was obtained with the one-pot 
difunctionalized DWCNTs, we also decided to develop a similar approach 
previously followed in our group for the successful manufacture of an ECL 
immunosensor based on CNTs for the detection of the marine toxin palytoxin 
(Figure 25 of Chapter 1, page 36).45  
In this approach, the difunctionalization was carried out by using two non-
competitive reactions on the CNTs: an addition to the basal plane and an 
amidation of carboxylic groups. In this way, the presence of one functional 
group will not affect the introduction of the next one, increasing the FD, which 
will lead to a higher functionalization with antibody. However, the amidation 
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step requires the presence of carboxylic groups, which must be introduced by 
an oxidation process. The main disadvantage of this oxidation process is the 
destruction of the electronical network of the tubes. However, the introduction 
of carboxylic groups will improve their solubility in polar solvents. 
Besides, another important difference of this approach was the performed 
sequence of reactions for the modification of the introduced functional groups 
(Figure 18). Since the amidation of the carboxylic groups of the ox-MWCNTs was 
performed after the introduction of the maleimidic groups, the introduction of 
two differently protected amino groups was not necessary. For this reason, only 
the Boc group was used as protector for the introduced amino groups. 
 
Figure 18. Non-competitive difunctionalization of ox-MWCNTs towards the final ox-
MWCNTs 7, which contains both the 7E11c antibody and primary amino groups. 
The purified MWCNTs were firstly shortened by an oxidation process in acidic 
conditions. Subsequently, phenyl moieties carrying a Boc-protected amine were 
covalently attached to the carbon structure by the thermal decomposition of 
the corresponding in situ generated diazonium salt from the commercially 
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available aniline 14. After deprotection of amino groups, the ox-MWCNTs were 
treated with the maleimide derivative 13, introducing maleimidic groups on the 
carbon structure to specifically link antibodies in a subsequent synthetic step. 
The carboxylic groups were condensed with Boc-monoprotected 
diaminotriethylene glycol (3) to obtain corresponding amides. Finally, the 7E11c 
antibody was specifically linked to the maleimidic moieties on the ox-MWCNTs 7 
by sulfur bonds. 
The obtained CNTs were characterized in terms of FD by TGA and KT (Figure 19, 
Table 3). The obtained ox-MWCNTs 2 showed a high FD of 176 µmol/g. The Boc 
deprotection of ox-MWCNTs 3 was clearly confirmed by a KT value of 160 
µmol/g. The subsequent introduction of maleimidic groups was confirmed by 
TGA. The functionalization of carboxylic groups with Boc-monoproctected 
diaminic chain 3 in ox-MWCNTs 5 was confirmed by TGA analysis with estimated 
FD of 283 µmol/g. The deprotection of Boc protected amine under acid 
conditions was also confirmed by KT, showing a value of 90 µmol/g. Finally, TGA 
also provided an approximate indication of the successful coupling of the 7E11c 
antibody to the CNTs, offering 3 µmol of antibody per g of CNTs for ox-MWCNTs 
7. 
  
Figure 19. TGA profiles for the synthesized ox-MWCNTs 
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Table 3. Characterization data of KT and TGA for the obtained ox-MWCNTs. 
Sample 
Weight loss (%) 
at 500 ºC in TGA 
Functionalization 
degree (µmol/g) 
KT value 
(µmol/g) 
Ox-MWCNTs 1 5.1 1142 - 
Ox-MWCNTs 2 8.8 176 - 
Ox-MWCNTs 3 8.0 202 160 
Ox-MWCNTs 4 9.1 154 - 
Ox-MWCNTs 5 16.1 283 - 
Ox-MWCNTs 6 11.6 97 90 
Ox-MWCNTs 7 57.3 3 - 
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2.4. Conclusions 
Arylation of the walls of DWCNTs through thermal decomposition of 
aryldiazonium compounds has been exploited. Particularly, the 
difunctionalization has been studied by different approaches (in sequential or 
one-pot processes), showing different results. We observed that for sequential 
difunctionalization, the first functional group introduced is predominant, while 
in one-pot difunctionalization, both functional groups are equally introduced. 
Moreover, we used the obtained material after one-pot difunctionalization of 
DWCNTs to produce a controllable modification of functional groups. The final 
material containing 0.52 µmol/g of anti-PSMA antibody and free amino groups 
accomplish the requirements for their use as component in the ECL-
immunosensing device.  
In addition, ox-MWCNTs were difunctionalized following a non-competitive 
approach, using different reactive points of the tubes. By using this approach, 
ox-MWCNTs functionalized with the anti-PSMA 7E11c antibody were obtained. 
In this case, FD with antibody of 3 µmol/g was obtained, a higher value than the 
obtained FD with the DWCNTs. 
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2.5. Experimental details 
2.5.1. Materials and techniques 
Chemicals 
All the chemicals and solvents were purchased from different commercial 
companies and they were used as received without further purification. 
CNTs (both DWCNTs and MWCNTs) were purchased from Nanocyl SA 
(Sambreville, Belgium). 
Raman spectroscopy 
Raman spectra were collected with an Invia Renishaw micro-spectrometer 
(100x) and a laser source at 633 nm. Solid samples on glass slide were measured 
without further preparation. At least 10 different points were measured on each 
sample, obtaining the final spectra as the average of every single spectrum. 
TGA 
TGA was performed on TgaQ500 (TA instruments) under N2, using 
approximately 1 mg of compound. Experiments consisted on equilibrating the 
temperature at 100 ºC for 20 min, followed by a ramp at 10 ºC/min up to 800 
ºC. 
Kaiser test 
KT was performed using a commercially available kit purchased from Sigma-
Aldrich. This kit contains 3 solutions: an 80 % phenol solution in ethanol 
(solution 1), potassium cyanide solution in pyridine (solution 2) and a 6 % 
ninhydrin solution in ethanol (solution 3). In a typical experiment, solution 1 (75 
µL) and solution 2 (100 µL) are added to approximately 0.5 mg of sample. The 
mixture is sonicated for 15 min and then, solution 3 (75 µL) is added. The 
mixture is heated at 120 ºC for 10 minutes. Subsequently, it is diluted with 
ethanol 60 % in water, up to 3 mL of final volume. The suspension is centrifuged 
and the resulting supernatant is collected, discarding the solid CNTs at the 
bottom. This test is positive if supernatant presents a dark blue color. 
For the quantitative determination of primary amino groups, the absorbance of 
the supernatant at 570 nm is recorded, setting the zero on the blank sample 
without CNTs. Then, FD was calculated using Equation 2, where A570nm is the 
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absorbance at 570 nm, V is the final volume after dilution (3 mL), ε570nm is the 
molar extinction coefficient (15000 M-1·cm-1), m is the exact mass of CNTs 
weighted and 106 is the correction factor to obtain FD in µmol/g. 
Equation 2                
           
 
  
   
UV-Vis spectroscopy 
UV-Vis-NIR spectra were recorded with a Cary 5000 spectrophotometer.  
NMR 
NMR spectra were obtained on a Varian Inova spectrometer (500 MHz 1H and 
125 MHz 13C) or on a JEOL Eclipse 400FT (400 MHz 1H). Chemical shifts are 
reported in ppm using the solvent residual signal as an internal reference (CDCl3: 
δH = 7.26 ppm, δC = 77.23 ppm). The resonance multiplicity is described as s 
(singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad signal). 
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2.5.2. Synthesis of organic compounds 
Synthesis of tert-butyl (2-(2-(2-aminoethoxy)ethoxy)ethyl)carbamate (3)43 
 
 
A solution of di-tert-butyl dicarbonate (1, 22.5 g, 101 mmol) in THF (150 mL) was 
added dropwise to a solution of 2,2′-(Ethylenedioxy)bis(ethylamine) (2, 30 mL, 
202 mmol) in THF (150 mL) at 0 ºC. After the addition, the mixture was allowed 
to reach r.t. and was stirred overnight. The solvents were removed under 
reduced pressure, the resulting crude was redisolved in DI water and filtered on 
celite. The aqueous phase was washed with PET (3 x 150 mL), then the product 
was extracted with AcOEt (3 x 150 mL), the combined organic layer was dried 
with dry Na2SO4 and filtered. The solvents were removed under reduced 
pressure, yielding the product as a yellow liquid (12.3 g, 49 %). 1H-NMR (400 
MHz, CDCl3) : 5.14 (br, 1H, NH), 3.60 (s, 4H, 2CH2), 3.55-3.49 (m, 4H, 2CH2), 
3.30 (m, 2H, CH2), 2.86 (t, J = 5.2 Hz, 2H, CH2), 1.43 (s, 9H, 3CH3), 1.29 (br, 2H, 
NH2) ppm. 
13C-NMR (125 MHz, CDCl3) : 155.9, 78.8, 73.1, 70.0, 41.5, 40.2, 28.3 
ppm. 
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Synthesis of tert-butyl (2-(2-(2-(1,3-dioxoisoindolin-2-
yl)ethoxy)ethoxy)ethyl)carbamate (5)43 
 
 
Phthalic anhydride (4, 7.3 g, 49.6 mmol) was added to a solution of compound 3 
(12.3 g, 49.6 mmol) in toluene (165 mL). Then, the mixture was stirred overnight 
at reflux temperature using a Dean-Stark collector. The solvent was removed 
under reduced pressure and the resulting crude was purified by column 
chromatography (SiO2; 1:1, Cyclohexane (Chx)/AcOEt). Product was obtained as 
a white solid (16.9 g, 90 %). 1H-NMR (400 MHz, CDCl3) : 7.85 (dd, Jab = 5.4 Hz, Jac 
= 3.0 Hz, 2H, Hphthal), 7.72 (dd, Jab = 5.4 Hz, Jac = 3.0 Hz, 2H, Hphthal) 5.04 (br, 1H, 
NH), 3.91 (t, J = 5.8 Hz, 2H, CH2), 3.75 (t, J = 5.8 Hz, 2H, CH2), 3.65-3.62 (m, 2H, 
CH2), 3.57-3.54 (m, 2H, CH2), 3.47, (t, J = 5.0 Hz, 2H, CH2), 3.25 (m, 2H, CH2), 1.6 
(s, 1H, NH), 1.44 (s, 9H, 3CH3) ppm. 
13C-NMR (125 MHz, CDCl3) : 166.8, 154.9, 
132.9, 130.9, 122.0, 77.4, 69.0, 68.8, 66.7, 59.0, 39.2, 36.1, 27.3 ppm. 
Double functionalization of carbon nanotubes 
 
 
71 
Synthesis of 2-(2-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)ethoxy)ethanaminium 
trifluoroacetate (6)43 
 
 
Trifluoroacetic acid (TFA, 17 mL) was added to a solution of 5 (16.5 g, 43.6 
mmol) in CH2Cl2 (17 mL). The mixture was stirred at r.t. for 1 hour. Then, toluene 
(50 mL) was added and the solvents were removed with reduced pressure, 
obtaining a brown oil. After sonicating in Et2O for 15 min, a solid precipitated. 
After filtration and drying, 6 was obtained as a white solid (17 g, 99 %). 1H-NMR 
(400 MHz, CDCl3) : 7.85 (dd, Jab = 5.4 Hz, Jac = 3.0 Hz, 2H, Hphthal), 7.71 (dd, Jab = 
5.4 Hz, Jac = 3.0 Hz, 2H, Hphthal), 3.87 (t, J = 5.2 Hz, 2H, CH2), 3.71 (t, J = 4.8 Hz, 4H, 
2CH2), 3.60 (s, 4H, 2CH2), 3.18 (t, J = 4.8 Hz, 2H, CH2) ppm. 
13C-NMR (125 MHz, 
CDCl3) : 168.6, 161.9, 134.2, 131.9, 123.4, 118.6, 70.1, 69.6, 68.2, 68.5, 39.7, 
37.3 ppm. 
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Synthesis of N-(2-(2-(2-(1,3-dioxoisoindolin-2-yl)ethoxy)ethoxy)ethyl)-4-
nitrobenzamide (8) 
 
 
Et3N (16 mL, 114 mmol) was added to a solution of 6 (15 g, 38 mmol) and 
benzoyl chloride (7, 7 g, 38 mmol). The mixture was stirred at r.t. overnight. 
Then, Et2O (250 mL) was added to the crude. Then, the resulting mixture was 
worked up with NaHCO3 (250 mL). The aqueous layer was separated and was 
subsequently extracted with Et2O (2 x 250 mL). The combined organic layer was 
dried with Na2SO4 and filtered. The solvents were removed under reduced 
pressure. The residue was purified by column chromatography (SiO2; 7:3, 
AcOEt/CH2Cl2), obtaining a yellow solid (9.3 g, 57 %). 
1H-NMR (500 MHz, CDCl3) 
: 8.27 (d, J = 8.5 Hz, 2H, HAr), 8.05 (d, J = 8.5 Hz, 2H, HAr), 7.78 (dd, Jab = 5.5 Hz, 
Jac = 3.0 Hz, 2H, Hphthal), 7.70 (dd, Jab = 5.5 Hz, Jac = 3.0 Hz, 2H, Hphthal), 7.23 (br, 
1H, NH), 3.90 (t, J = 5.5 Hz, 2H, CH2), 3.76 (t, J = 5.5 Hz, 2H, CH2), 3.66-3.64 (m, 
2H, CH2), 3.61-3.59 (m, 6H, 3CH2), 1.93 (s, 1H, NH) ppm. 
13C-NMR (125 MHz, 
CDCl3) : 168.4, 166.4, 149.5, 140.1, 134.1, 132.0, 128.4, 123.7, 123.2, 70.2, 
69.9, 69.4, 68.0, 40.0, 37.3 ppm. 
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Synthesis of 4-amino-N-(2-(2-(2-(1,3-dioxoisoindolin-2-
yl)ethoxy)ethoxy)ethyl)benzamide (9) 
 
 
A catalytic amount of Pd on activated charcoal (10 % wt.) was added to a 
solution of compound 8 (9 g, 21 mmol) in THF (180 mL) and EtOH (720 mL). In 
order to obtain an inert environment, vacuum/Ar cycles were performed. Then, 
H2 is introduced in the reaction medium. The mixture was stirred at r.t. for 24 h, 
refilling H2 when necessary. The crude was filtered on celite. Then, the solvents 
were removed under reduced pressure and the residue was purified by column 
chromatography (SiO2; 4:96, MeOH/CH2Cl2). The product was obtained as a 
yellow oil (7.5 g, 90%). 1H-NMR (500 MHz, CDCl3) : 7.70 (dd, Jab = 5.5 Hz, Jac = 
3.0 Hz, 2H, Hphthal), 7.60 (dd, Jab = 5.5 Hz, Jac = 3.0 Hz, 2H, Hphthal), 7.55 (d, J = 8.5 
Hz, 2H, HAr), 6.85 (t, J = 4.8 Hz, 1H, NH), 6.54 (d, J = 8.5 Hz, 2H, HAr), 3.81 (t, J = 
5.8 Hz, 2H, CH2), 3.67 (t, J = 5.8 Hz, 2H, CH2), 3.58-3.56 (m, 2H, CH2), 3.51-3.47 
(m, 6H, 3CH2), 3.35 (s, 1H, NH2) ppm. 
13C-NMR (125 MHz, CDCl3) : 168.3, 167.3, 
149.8, 134.0, 131.8, 128.7, 123.5, 123.1, 113.9, 70.0, 69.9, 69.8, 67.8, 39.45, 
37.1 ppm. 
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Synthesis of tert-butyl (2-(2-(2-(4-
nitrobenzamido)ethoxy)ethoxy)ethyl)carbamate (10) 
 
 
Et3N (15 mL, 109 mmol) was added to a solution of 3 (9 g, 36 mmol) and benzoyl 
chloride (7, 7 g, 36 mmol). The mixture was stirred at r.t. overnight. Then, Et2O 
(300 mL) was added to the crude. Then, the resulting mixture was worked up 
with NaHCO3 (300 mL). The aqueous layer was separated and was subsequently 
extracted with Et2O (2 x 300 mL). The combined organic layer was dried with 
Na2SO4 and filtered. The solvents were removed under reduced pressure. The 
residue was purified by column chromatography (SiO2; 9:1 to 7:3, 
CH2Cl2/AcOEt). Product was a white solid (12.2 g, 85 %).
 1H-NMR (500 MHz, 
CDCl3) : 8.26 (d, J = 7.5 Hz, 2H, HAr), 7.96 (d, J = 7.5 Hz, 2H, HAr), 7.00 (br, 1H, 
NH), 4.95 (br, 1H, NH), 3.67-3.53 (m, 10H, 5CH2), 3.27 (br, 2H, CH2), 1.39 (s, 9H, 
3CH3) ppm. 
13C-NMR (125 MHz, CDCl3) : 166.5, 156.0, 149.5, 140.1, 128.3, 
123.7, 79.5, 70.8, 70.3, 70.2, 69.5, 41.8, 40.3, 28.4 ppm. 
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Synthesis of tert-butyl (2-(2-(2-(4-
aminobenzamido)ethoxy)ethoxy)ethyl)carbamate (11) 
 
 
A catalytic amount of Pd on activated charcoal (10 % wt.) was added to a 
solution of compound 10 (11 g, 28 mmol) in THF (220 mL) and EtOH (880 mL). In 
order to obtain an inert environment, vacuum/Ar cycles were performed. Then, 
H2 is introduced in the reaction medium. The mixture was stirred at r.t. for 24 h, 
refilling H2 when necessary. The crude was filtered on celite. Then, the solvents 
were removed under reduced pressure and the residue was purified by column 
chromatography (SiO2; 4:96, MeOH/CH2Cl2), obtaining a yellow oil (10 g, 98 %). 
1H-NMR (500 MHz, CDCl3) : 7.56 (d, J = 8 Hz, 2H, HAr), 6.72 (br, 1H, NH), 6.58 (d, 
J = 8.5 Hz, 2H, HAr), 5.13 (br, 1H, NH), 3.59-3.56 (m, 8H, 4CH2), 3.48 (t, J = 5.3 Hz, 
2H, CH2), 3.38 (s, 0.5H, NH2), 3.25-3.24 (m, 2H, CH2), 1.38 (s, 9H, 3CH3) ppm. 
13C-
NMR (125 MHz, CDCl3) : 167.4, 156.1, 149.9, 128.7, 123.7, 114.0, 79.3, 70.2, 
70.1, 70.0, 50.4, 40.3, 39.6, 28.4 ppm. 
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Synthesis of 2,5-dioxopyrrolidin-1-yl 3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-
yl)propanoate (13) 
 
 
β-Alanine (16, 4.5 g, 51 mmol) was added to a solution of maleic anhydride (15, 
5 g, 51 mmol) in freshly degassed DMF (50 mL) under Ar. The solution was 
stirred for 1 h. The resulting mixture was cooled with an ice bath and N-
hydroxysuccinimide (NHS, 17, 7.34 g, 63.7 mmol) and N,N’-
dicyclohexylcarbodiimide (DCC, 21 g, 102 mmol) were added. The mixture was 
allowed to reach r.t. and stirred under Ar atmosphere overnight. The solution 
was filtered on celite and poured into a separation funnel containing DI water 
(250 mL). Then, the aqueous layer was extracted with CH2Cl2 (3 x 250 mL). The 
combined organic layers were dried with sodium sulfate and filtered. The 
product was purified by recrystallization with PET from CH2Cl2. Product was a 
white powder (4 g, 30 %) and was stored at 4 ºC. 1H-NMR (400 MHz, CDCl3) : 
6.74 (s, 2H, -CH=CH-), 3.94 (t, J = 7 Hz, 2H, CH2), 3.02 (t, J = 7 Hz, 2H, CH2),2.82 (s, 
4H, 2CH2, succ) ppm. 
13C-NMR (125 MHz, CDCl3) : 170.0, 165.9, 134.2, 33.0, 29.8, 
25.6 ppm. 
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2.5.3. CNTs modification 
Synthesis of DWCNTs 1 
 
 
Pristine DWCNTs (39.6 mg) were dispersed in NMP (79 mL) by sonication for 15 
min. The aniline 9 (1.6 g, 3.9 mmol) was added and the suspension was heated 
to 80 ºC. A solution of isopentyl nitrite (12, 800 µL, 5.9 mmol) in NMP (59 mL) 
was added dropwise to the reaction mixture, which was allowed to react at 80 
ºC for 4 h. The suspension was filtered on a teflon membrane (Millipore, JHWP, 
0.45 µm), and the solid was washed with DMF until a colorless filtrate was 
obtained. Afterward, the DWCNTs 1 were collected and redispersed in DMF 
(150 mL) for 5 min. The reaction mixture was filtered under same conditions, 
and the process was repeated 3 times. This washing sequence was continued in 
an identical manner with alternating cycles of MeOH (3 x 150 mL), deionized (DI) 
water (6 x 150 mL), MeOH (150 mL) and AcOEt (150 mL). Finally, the solid 
sample was rinsed in the filter funnel with Et2O and left to dry at r.t. under 
vacuum. Obtained mass: 46.4 mg, FD: 273 µmol/g (TGA), 14 µmol/g (KT), ID/IG: 
0.23. 
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Synthesis of DWCNTs 2 
 
 
The DWCNTs 1 (38 mg) were dispersed in NMP (76 mL) by sonication for 15 min. 
The aniline 11 (1.4 g, 3.8 mmol) was added and the suspension was heated to 80 
ºC. A solution of isopentyl nitrite (12, 765 µL, 5.7 mmol) in NMP (57 mL) was 
added dropwise to the reaction mixture, which was allowed to react at 80 ºC for 
3 h. The suspension was filtered on a teflon membrane (Millipore, JHWP, 0.45 
µm), and the solid was washed with DMF until a colorless filtrate was obtained. 
Afterward, the DWCNTs 2 were collected and redispersed in DMF (100 mL) for 5 
min. The reaction mixture was filtered under same conditions, and the process 
was repeated 3 times. This washing sequence was continued in an identical 
manner with alternating cycles of MeOH (3 x 100 mL), DI water (3 x 150 mL), 
MeOH (100 mL) and AcOEt (100 mL). Finally, the solid sample was rinsed in the 
filter funnel with Et2O and left to dry at r.t. under vacuum. Obtained mass: 36.6 
mg, FD: 48 µmol/g (TGA), 20 µmol/g (KT), ID/IG: 0.33. 
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Synthesis of DWCNTs 3 
 
 
Hydrazine monohydrate (3 mL) was added to a suspension of DWCNTs 2 (30 mg) 
in ethanol (150 mL). The mixture was stirred at r.t. overnight. The obtained 
suspension was filtered on a teflon membrane (Millipore, JHWP, 0.45 µm), and 
washed by applying redispersion/filtration cycles with DI water (3 x 150 mL) and 
MeOH (150 mL). Finally, the sample was rinsed with Et2O and dried under 
vacuum. Obtained mass: 28.81 mg, FD: 73 µmol/g (KT). 
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Synthesis of DWCNTs 4 
 
 
The DWCNTs 3 (20 mg) were dispersed in anhydrous DMF (40 mL) by sonication 
for 15 minutes while Ar was bubbled into the solvent. The maleimidic derivative 
13 (61 mg, 0.23 mmol) and ethylenediisopropylamine (EDIPA, 69 µL, 0.4 mmol) 
were added and the mixture was stirred under Ar at r.t. overnight. The reaction 
suspension was filtered on a teflon membrane (Millipore, JHWP, 0.45 µm), 
rinsed with DMF and washed by redispersion/filtration cycles with DMF (4 x 100 
mL), MeOH (3 x 100 mL), and finally it was rinsed with Et2O. Obtained mass: 
19.46 mg, FD: 35 µmol/g (KT). 
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Synthesis of DWCNTs 5 
 
 
The DWCNTs 4 (9 mg) were dispersed in 1,4-dioxane (60 mL) by sonication. 
Then, HCl (33%, 30 mL) was added and mixture was stirred at r.t. overnight. The 
suspension was filtered on a teflon membrane (Millipore, JHWP, 0.45 µm), 
rinsed with DI water and washed by redispersion/filtration with DI water (3 x 
150 mL), MeOH (100 mL) and rinsed with Et2O. Obtained mass: 7.63 mg, FD: 38 
µmol/g (KT). 
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Synthesis of DWCNTs 6 
 
Pristine DWCNTs (40 mg) were dispersed in NMP (80 mL) by sonication for 15 
min. The anilines 9 (1.6 g, 4 mmol) and 11 (1.5 g, 4 mmol) were added and the 
suspension was heated to 80 ºC. A solution of isopentyl nitrite (12, 1.6 mL, 12 
mmol) in NMP (120 mL) was added dropwise to the reaction mixture, which was 
allowed to react at 80 ºC for 3 h. The suspension was filtered on a teflon 
membrane (Millipore, JHWP, 0.45 µm), and the solid was washed with DMF 
until a colorless filtrate was obtained. Afterward, the DWCNTs 6 were collected 
and redispersed in DMF (150 mL) for 5 min. The reaction mixture was filtered 
under same conditions, and the process was repeated 3 times. This washing 
sequence was continued in an identical manner with alternating cycles of MeOH 
(3 x 150 mL), DI water (3 x 150 mL), MeOH (150 mL) and AcOEt (150 mL). Finally, 
the solid sample was rinsed in the filter funnel with Et2O and left to dry at r.t. 
under vacuum. Obtained mass: 46.8 mg, FD: 280 µmol/g (TGA), 19 µmol/g (KT), 
ID/IG: 0.21. 
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Synthesis of DWCNTs 7 
 
 
Hydrazine monohydrate (3 mL) was added to a suspension of DWCNTs 6 (30 mg) 
in ethanol (150 mL). The mixture was stirred at r.t. overnight. The obtained 
suspension was filtered on a teflon membrane (Millipore, JHWP, 0.45 µm), and 
washed by applying redispersion/filtration cycles with DI water (3 x 150 mL) and 
MeOH (150 mL). Finally, the sample was rinsed with Et2O and dried under 
vacuum. Obtained mass: 28.76 mg, FD: 58 µmol/g (KT). 
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Synthesis of DWCNTs 8 
 
 
The DWCNTs 7 (22 mg) were dispersed in anhydrous DMF (44 mL) by sonication 
for 15 minutes while Ar was bubbled into the solvent. The maleimidic derivative 
13 (94 mg, 0.35 mmol) and EDIPA (153 µL, 0.88 mmol) were added and the 
mixture was stirred under Ar at r.t. overnight. The reaction suspension was 
filtered on a teflon membrane (Millipore, JHWP, 0.45 µm), rinsed with DMF and 
washed by redispersion/filtration cycles with DMF (4 x 100 mL), MeOH (3 x 150 
mL), and finally it was rinsed with Et2O. Obtained mass: 21.57 mg, FD: 33 
µmol/g (KT). 
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Synthesis of DWCNTs 9 
 
 
The DWCNTs 8 (15 mg) were dispersed in 1,4-dioxane (100 mL) by sonication. 
Then, HCl (33%, 50 mL) was added and mixture was stirred at r.t. overnight. The 
suspension was filtered on a teflon membrane (Millipore, JHWP, 0.45 µm), 
rinsed with DI water and washed by redispersion/filtration with DI water (3 x 
150 mL), MeOH (100 mL) and rinsed with Et2O. Obtained mass: 14.41 mg, FD: 
57 µmol/g (KT). 
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Synthesis of DWCNTs 10 
 
 
The DWCNTs 9 (2.52 mg) were added to a PBS solution (1.8 mL) at pH 8.0 of the 
antibody 7E11c (1.8 mg), which contains 2 SH groups per antibody. The solution 
was sonicated (10 min) in a sonication bath with ice and then it was gently 
shaken for 24 hours at r.t. The mixture was diluted with fresh PBS at pH 8.0 to a 
total volume of 15 mL. Then, it was centrifuged (2000 rpm, 4 min) in a Vivaspine 
20 centrifuge tube (300 KDa cut-off membrane). This centrifugation process was 
repeated 5 more times with fresh PBS. The pH was exchanged to 7.4 by dialysis 
in PBS for 48 hours using a 300 KDa cut-off membrane. After the dialysis, the 
product was stored at 4 ºC as a suspension with a concentration of 0.625 mg/mL 
in PBS. 
A fraction of this suspension was dialyzed in Milli-Q water in order to remove all 
PBS salts to perform TGA. A weight loss of 23.7 % was obtained, corresponding 
to a FD of 0.52 µmol/g. 
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Synthesis of ox-MWCNTs 1 
 
 
Pristine MWCNTs (200 mg) were sonicated in a mixture of HNO3 and H2SO4 (48 
mL) in a 1:3 ratio for 7 h at 10-30 ºC. After sonication, the resulting mixture was 
poured onto DI water (700 mL) and filtered on a teflon membrane (Millipore, 
JHWP, 0.45 µm). The black solid was then washed by redispersion and filtration 
in DI water, in a 0.1 M solution of NaOH, DI water, DMF and finally in THF. The 
ox-MWCNTs 1 were recovered from the filter as a black solid. Obtained mass: 
150 mg, FD: 1142 µmol/g (TGA). 
Synthesis of ox-MWCNTs 2 
 
 
The ox-MWCNTs 1 (30 mg) were dispersed in DMF (30 mL) by sonication for a 
couple of minutes. The aniline 14 (660 mg, 3 mmol) was added, followed by 
dropwise addition of isopentyl nitrite (12, 1.45 mL, 10.8 mmol). The resulting 
suspension was heated up to 80 ºC and stirred for 2 hours. Then, the mixture 
was filtered on a teflon membrane (Millipore, JHWP, 4.5 µm) and washed by 
redispersion and filtration using DMF, MeOH, DI water, MeOH, AcOEt and 
finally, rinsed over the filter with Et2O. The ox-MWCNTs 2 were recovered from 
the filter as a black solid. Obtained mass: 25 mg, FD: 176 µmol/g (TGA). 
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Synthesis of ox-MWNCTs 3 
 
 
The ox-MWCNTs 2 (20 mg) were dispersed in a HCl solution (20 mL, 4 M) by 
sonication and the mixture was stirred at r.t. overnight. The CNTs were filtered 
on a teflon membrane (Millipore, JHWP, 0.45 µm) and washed by redispersion 
followed by filtration in DI water, then EtOH, and finally rinsed with Et2O. The 
ox-MWCNTs 3 were recovered from filter as black solid. Obtained mass: 15.1 
mg, FD: 202 µmol/g (TGA), 160 µmol/g (KT). 
Synthesis of ox-MWCNTs 4 
 
 
The ox-MWCNTs 3 (13 mg) and maleimidic derivative 13 (138 mg, 520 µmol) 
were dissolved in dry DMF (13 mL). Then, EDIPA (90 µL, 520 µmol) was added 
and the reaction was stirred at r.t. overnight. The mixture was filtered on a 
teflon membrane (Millipore, JHWP, 0.45 µm) and rinsed with DMF. Then, the 
solid was washed by redispersion and filtration in DI water, DMF, EtOH and 
finally rinsed with Et2O, affording the ox-MWCNTs 4 as black solid. Obtained 
mass: 11.4 mg, FD: 154 µmol/g (TGA). 
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Synthesis of ox-MWCNTs 5 
 
 
The ox-MWCNTs 4 (9 mg) were dispersed in DMF (10 mL). Then, the compound 
3 (58 mg, 230 µmol), EDC (35.65 mg, 230 µmol), HOBt (32 mg, 230 µmol) and 
DMAP (28.06 mg, 23 µmol), were added at 0 ºC. The mixture was allowed to 
reach r.t. and it was stirred for 2 days. The mixture was filtered on a teflon 
membrane (Millipore, JHWP, 0.45 µm) and it was washed by redispersion and 
filtration with DI water, DMF and MeOH. Finally, the CNTs on the filter were 
rinsed with Et2O, affording of the ox-MWCNTs 5. Obtained mass: 8.3 mg, FD: 
283 µmol/g (TGA). 
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Synthesis of ox-MWNCTs 6 
 
 
The ox-MWCNTs 5 (7 mg) were dispersed in a mixture of TFA and CH2Cl2 (7 mL, 
1:1). Then, the suspension was stirred at r.t. overnight. The resulting suspension 
was filtered on a teflon membrane (Millipore, JHWP, 0.45 µm) and washed by 
redispersion and filtration with MeOH and finally rinsed with Et2O. The ox-
MWCNTs 6 were recovered as black solid. Obtained mass: 5.5 mg, FD: 97 
µmol/g (TGA), 90 µmol/g (KT). 
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Synthesis of ox-MWCNTs 7 
 
 
The ox-MWCNTs 6 (3.23 mg) were added to a solution of Ab 7E11c in PBS (3 mL, 
0.77 mg/mL, pH = 7.2) and was carefully sonicated for 10 min in an ice bath. The 
obtained suspension was gently shaken at 11 ºC for 24 hours. The mixture was 
centrifuged at 2000 rpm for 4 min using a centrifuge tube with membrane 
(Vivaspin 20, 300000 Da cut-off). Centrifugation was repeated 5 times with 15 
mL of fresh PBS to remove free Ab. The remaining CNTs suspension was dialyzed 
in PBS using a dialysis sack (300000 Da cut-off). 
A small fraction of final suspension (1 mL) was centrifuged using a centrifugal 
filter device (Amicon Ultra, 50,000 cut-off membrane) and then centrifuged 5 
times with Milli-Q water, in order to remove PBS salts before performing TGA. 
After centrifugation, the sample was freeze-dried. TGA profile showed a neat 
weight loss of 45.7 % for ox-MWCNTs 7, corresponding to 3 µmol of Ab 7E11c 
per gram of sample. 
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Chapter 3 
Functionalization of graphene 
derivatives 
 
3.1. Introduction 
Graphene is the most promising material of the 21st century due to a unique set 
of electronic, mechanical and thermal properties.1 Consequently, graphene 
derivatives exhibit a wide variety of applications in different areas, including 
biosensing.2 For this reason, chemical functionalization of graphene is a topic of 
paramount importance, because it allows the fine-tuning of its chemical and 
physical properties. 
3.1.1. Classification of graphene derivatives 
Graphene can be obtained through different techniques, as explained in the 
general introduction in Chapter 1. Hence, graphene can be obtained with very 
different characteristics by varying the production method. For this reason, the 
terms graphene derivative or graphene-based material are preferred to 
differentiate the different types of graphene that can be obtained. 
In this context, the European GRAPHENE Flagship project proposed in 2014 a 
classification of the different graphene derivatives based on three main 
characteristics: lateral size, carbon/oxygen ratio (C/O) and number of stacked 
layers (Figure 1).3 As consequence, when working with graphene derivatives, the 
determination of these three parameters should be considered of main 
importance when characterizing the material. In particular, microscopy 
techniques, as TEM or AFM, can be used to obtain the morphological 
parameters: number of stacked layers and lateral dimension.4 In addition, 
Raman spectroscopy can be used to obtain the number of layers.5 On the other 
hand, the C/O ratio can be known by using elemental analysis or XPS.6 
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Figure 1. Grid for the classification of graphene derivatives. Different ideal materials are 
represented at the corners. Adapted from Wick et al. 2014.
3
 
3.1.2. Functionalization of graphene 
Although they are different in reactivity, the study of CNTs functionalization 
served as starting point for the study of the functionalization of graphene and 
its derivatives. Functionalization types can be divided in three main categories: 
modification of oxygenated groups, non-covalent functionalization and covalent 
functionalization on the basal plane. 
3.1.2.1. Modification of oxygenated groups 
The large number of oxygenated groups present in graphene derivatives with 
low C/O ratio (GO and rGO) can be chemically modified by the introduction of 
other groups.6 
One of the most common modifications within this category is the addition of 
nucleophilic species, such as amines or hydroxyls, to the carboxylic acids, 
producing amide and ester bonds, respectively. Generally, this coupling 
reactions require the activation of the acid group using different coupling 
agents: thionyl chloride (SOCl2), 1-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide (EDC), N,N’-Dicyclohexylcarbodiimide (DCC) or benzotriazoles.7 
This method has been employed for the attachment of small molecules and 
substituted amino or hydroxyl groups. In particular, the incorporation of 
substituted amines is the most common approach for many applications. For 
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instance, polymers, porphyrins, fullerenes or proteins have been attached to GO 
using amine-to-amide coupling (Figure 2).8 
 
Figure 2. Amide coupling on GO performed with coupling agents for the incorporation of 
different molecules of interest: A) porphyrins,
8a
 B) fullerenes,
8a
 and C) proteins.
8b
 
On the other hand, epoxy groups can be easily modified through ring-opening 
reactions under various conditions. As consequence of this ring-opening, a new 
hydroxyl group is generated during the introduction of the nucleophilic group. 
Many examples of epoxy opening through nucleophilic attack of substituted 
amines can be found in the literature.9 However, the introduction of azide 
groups (-N3) via epoxy opening during treatment with sodium azide is one of the 
most interesting reactions. Azide groups introduced in GO through this method 
can be used to react with alkynes, as traditional click reactions (Figure 3).10 
 
Figure 3. Introduction of azide groups through opening of epoxy groups, followed by 
click reaction. 
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3.1.2.2. Non-covalent functionalization on the basal plane 
The modification of graphene surface by non-covalent interaction offers, as in 
the case of CNTs, a non-destructive way to manipulate graphene. This method 
consists on the physical adsorption of molecules, based in π-interactions and 
Vand der Waals forces. For this reason, the electronic network of graphene is 
not altered.11 However, non-covalent interactions are weaker than covalent 
bonds and non-covalent functionalization is generally less stable than the 
covalent one. 
The adsorption of pyrene derivatives is the typical example for π-interactions 
with graphene. Herein, irreversible binding of pyrene-based molecules on the 
surface of graphene has been achieved.12 Using different pyrene-based 
molecules, different properties can be introduced. For instance, the use of 
pyrene linked to the NHS group allows the introduction of proteins through the 
nucleophilic substitution.13 In addition, a better binding can be achieved with a 
higher number of pyrene moieties per molecule, as for example, the reported 
“tripodal” molecules (Figure 4A).14 Other polyaromatic molecules can strongly 
bind to graphene surface through π-π interactions.15 An interesting example was 
performed by Wang et al. by the formation of a self-assembled monolayer 
(SAM) of perylenes on the surface of graphene (Figure 4B).16 
 
 
 
Figure 4. Non-covalent functionalization of graphene derivatives through π-interactions. 
A) “Tripodal” molecule bound to graphene through three pyrene moieties.
17
 B) Top: 
Schematic representation of perylene SAM. Bottom: Scanning tunnelling microscopy 
(STM) images of SAM of perylene molecules on the surface of graphene.
16
 
A) B) 
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Moreover, as in the case of CNTs, graphene can be non-covalently 
functionalized with polymers of different nature. Boundless examples can be 
found in the literature. Some representative examples include graphene 
functionalized with polystyrene, nafion, polyaniline or poly(3,4-ethylene 
dioxythiophene) (PEDOT), among others.18 
In addition, graphene is an ideal substrate for the dispersion of NPs, due to its 
large active surface area (Figure 5A). Generally, metallic NPs are generated by 
the reduction of metal salts. For this reason, a common method for the 
deposition of NPs on graphene surface involves the use of GO with 
simultaneous reduction from GO to rGO and from metal salts to metal NPs. 
Different reduction methods can be employed as annealing, microwaves or 
chemical reduction with sodium borohydride (NaBH4).
19 Furthermore, metal 
oxide NPs have also been non-covalently deposited on graphene surface. SnO2, 
TiO2 or Fe3O4 NPs are some examples of metal oxide NPs that have been 
deposited on graphene.20 In particular, Fe3O4 NPs are of great interest, due to 
their magnetic properties. As shown on Figure 5B, rGO functionalized with Fe3O4 
NPs can be separated from an aqueous medium with the help of a magnet. 
Hence, this material can be applied in different applications, as water cleaning, 
drug delivery or magnetic resonance imaging.21 
 
Figure 5. Non-covalent functionalization of graphene derivatives with NPs. A) TEM 
image of Pd NPs generated with simultaneous reduction of GO.
19b
 B) Magnetic 
separation from aqueous medium of graphene-magnetic NPs composite.
21a 
3.1.2.3. Covalent functionalization of graphene derivatives on the basal 
plane 
Graphene is less reactive than other CNMs, as CNTs or fullerenes, due to the 
lower curvature of the basal plane. However, graphene is not a totally flat 
material and it exhibits intrinsic out-of-plane deformations. Carbon atoms at 
A) B
) 
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corrugated parts, edges, and defects are more reactive than those in the basal 
plane and can undergo chemical reactions leading to covalent 
functionalization.22 On the one hand, by the formation of a covalent bond, 
products obtained by this kind of functionalization generally present a high 
stability. On the other hand, the loss of sp2 conjugation affects the electronic 
properties. 
Virtually, every covalent functionalization described for CNTs have also been 
achieved with different graphene derivatives, including fluorination, radical 
addition, Diels Alder cycloaddition, carbene cycloaddition, nitrene cycloaddition 
and 1,3-dipolar cycloaddition (Figure 6).23 
 
Figure 6. Covalent reactions on graphene. A) Fluorination, B) aryl diazonium addition, C) 
nitrene cycloaddition, D) 1,3-dipolar cycloaddition and E) aryne cycloaddition. 
One important feature of graphene is that it presents a zero band gap. This 
characteristic makes graphene a special reagent towards Diels Alder 
cycloadditions, since it can act as both diene or dienophile (Figure 7).24 One 
disadvantage (or advantage, depending on the application) of this 
functionalization is its reversibility, since retro-Diels Alder can also happen. 
 
Figure 7. Dual character of graphene as diene (A) and dienophile (B) in Diels Alder 
cycloadditions. 
Many covalent modifications are described for graphene.25 However, radical 
additions, in general, and aryldiazionium reaction, in particular, is the most 
employed method. Successful aryldiazionium reaction on graphene has been 
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described using both ex situ-prepared and in situ-generated aryldiazionium 
compounds on graphene dispersions, graphene deposited on substrates and GO 
(Figure 6B).6, 22 Other examples of radical arylations include the use of peroxides 
(Figure 8A)26 or iodonium salts (Figure 8B).27 In addition, a particular case of 
radical functionalization of aromatic moieties is the reversible Kolbe reaction 
with naphthylacetic acid (Figure 8C).28 
 
Figure 8. Radical additions on graphene. Radicals are generated from A) benzyl 
peroxides, B) aryliodonium salts and C) naphthylacetic acid. 
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3.2. Aim of the work 
Following the same strategy taken with CNTs, the next objective was the study 
of the functionalization of graphene derivatives in order to obtain an ECL 
immunosensor for the detection of prostate cancer.  
Different graphene derivatives and different covalent modifications were 
adopted towards a difunctional material. As with CNTs, the objective was to 
obtain a material containing both maleimide groups for the attachment of the 
anti-PSMA antibody and primary amino groups for the immobilization on the 
modified surface of an electrode (Figure 9). 
 
Figure 9. General design of target material. Curved line represents any functionalization 
method. 
Moreover, we studied a first approach for the non-covalent functionalization of 
graphene obtained by CVD (CVDG). In this particular case, CVDG is already 
supported on the surface of the electrode. Consequently, only one 
functionalization was necessary for the attachment of the antibody due to the 
high adsorption of G on the surface of the electrode. 
Anchor point for attaching antibody
Anchor point for linking electrode
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3.3. Results and discussion 
Within this section, modification of different graphene derivatives will be 
described by using different synthetic approaches: partial coverage of amino 
groups on monofunctionalized reduced graphene oxide (rGO) with maleimidic 
units; one-pot difunctionalization of rGO; and non-competitive 
difunctionalization of rGO. Finally, studies about the non-covalent 
functionalization of CVDG will be presented. 
3.3.1. Difunctional functionalized reduced graphene oxide 
In this first approach, rGO was modified in only one functionalization step with 
aniline 9 by aryldiazonium addition, instead of performing a difunctionalization, 
in which two different moieties are introduced. Difunctionality necessary for the 
biosensor assembly was achieved by the partial coverage of free amino groups 
(obtained after phthalimide deprotection) with maleimide-terminated small 
chain. 
The preparation of rGO was the first step for this synthesis. It was carried out 
through chemical reduction of graphene oxide (GO), which had been prepared 
by oxidation of graphite through the improved Hummers’ method by Tour 
(TGO).29 As displayed in Figure 10, rGO 1 was obtained after treating an aqueous 
dispersion of TGO with hydrazine monohydrate in a basic medium and high 
temperature. After copious washing with milli-Q water by dialysis and filtration, 
rGO 1 was obtained as a black solid. 
 
Figure 10. Chemical reduction of TGO with hydrazine monohydrate. 
The reduction, or in other words the removal of oxygenated groups, was 
demonstrated with characterization techniques. TGA profile, shown on Figure 
11, demonstrated the reduction, since sample rGO 1 did not present the high 
weight loss of TGO at 250 ºC, which is due to the thermal removal of 
oxygenated groups. Moreover, we confirmed the reduction with Raman 
spectroscopy. The characteristic fluorescence of GO, which can be observed in 
the raw spectrum of TGO, was not present in the spectrum of rGO 1. In addition, 
we observed an increase of the D band in the normalized spectrum to the G 
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band after baseline correction of the spectrum of TGO. This observation is in 
agreement with the reduction from TGO to rGO, confirming the success of this 
reaction.30 
 
 
Figure 11. Characterization for GO reduction. A) TGA and B) Raman spectra of TGO 
(black: solid line is for raw spectrum and dotted line for spectrum after correction of the 
baseline) and rGO 1 (red). 
Subsequently, modification of rGO 1 was performed through a radical arylation, 
by thermal decomposition of the aryldiazionium compound generated in situ 
from aniline 9 (Figure 12A), in a similar procedure as explained for DWCNTs in 
previous chapter. The success of this reaction was demonstrated with TGA 
(Figure 12B) by the higher weight loss of rGO 2 compared to rGO 1, a 4.7 % 
more at 500 ºC, corresponding to a FD of 124 µmol/g. Unfortunately, Raman 
spectroscopy cannot be used to characterize radical additions on rGO, since this 
material already presents a high D band due to the presence of large number of 
defects. Therefore, all rGO samples will be fully characterized by TGA and KT. 
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Figure 12. A) Aryldiazionioum reaction on rGO. B) TGA profile of rGO 1 (red) and rGO 2 
(blue). 
Subsequently, removal of phthalimide groups of rGO 2 was achieved by 
treatment with hydrazine monohydrate (Figure 13), affording a KT value of 277 
µmol of primary amino groups per gram of sample. In next step, the partial 
coverage of amino groups of rGO 3 with maleimidic derivative 13 was 
performed (Figure 13). Characterization of the obtained rGO 4 demonstrated 
the success of this partial coverage by a FD of 118 µmol/g by KT. This value is 
much smaller than the obtained for rGO 3 (277 µmol/g), which demonstrate the 
incorporation of maleimide group; however, it is also a big value, which means 
that primary amino groups were still present. 
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Figure 13. Partial coverage of primary amino groups with maleimide-terminated small 
chain. 
By this partial coverage, we obtained rGO 4, a desired final material, containing 
both maleimide functional group and free amines, with only one modification 
on the basal plane of graphene. Thus, reducing the number of necessary steps, 
we reached to a final material that can be used for the attachment of the anti-
PSMA antibody. 
Consequently, anti-PSMA 7E11c antibody previously modified with thiol groups 
(see section 2.3.2) was covalently attached to maleimide groups contained on 
rGO 4, affording Ab-functionalized rGO 5 (Figure 14). 
 
Figure 14. Antibody attachment to reduced graphene oxide. 
Sample rGO 5 was characterized by UV-Vis spectroscopy and TGA. The UV-Vis 
spectrum, shown on Figure 15A, was measured using a 1 mg/mL suspension of 
rGO 5 in PBS at pH 7.4. We can observe the characteristic band of antibodies at 
280 nm. The sample rGO 5 was also characterized by TGA. A small fraction of 
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rGO 5 suspension was washed with Milli-Q water using centrifuge filters, in 
order to remove all PBS salts. After freeze-drying, sample was ready to be 
characterized by TGA. As shown on Figure 15B, the profile of rGO 5 presented a 
slight increase at 500 ºC by comparison to rGO 4. Difference in weight loss was 
3.6 %, corresponding to a low FD of 0.2 µmol of antibody per gram of sample. 
 
 
Figure 15. A) UV spectrum of rGO 5. B) TGA profile comparing samples rGO 4 (pink) and 
rGO 5 (purple). 
The quantification of antibody in rGO 5 resulted in a very low functionalization, 
which makes this material an unsuitable candidate as component of the 
envisioned biosensor. However, we confirmed that the primary amino groups 
that remained after partial coverage with maleimide could be used for the 
covalent attachment of rGO to the modified surface of ITO electrode. 
In order to covalently anchor amino-functionalized rGO 5 onto the surface of 
ITO electrode, a layer of a polymer containing N-succinimide ester groups was 
introduced. The role of N-succinimide is to activate the carboxylic groups, 
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allowing an effective amine-to-amide coupling. Poly-(N-succinimide acrylate) 
(PNSA) was electrochemically grafted on the surface of ITO electrode (Figure 
16). The reaction was performed introducing the electrode in a solution of N-
succinimide acrylate (NSA, 18) and tetrabutylammonium hydroxide (TBAH) in 
dry DMF in a closed flask with Ar bubbling.31 After the removal of excess of NSA 
monomer and TBAH, rGO 5 was attached. For this purpose, a small amount of 
EDC was solved in 40 µL of a dispersion of rGO 5 in PBS. Then, it was deposited 
on the electrode surface. The modified electrode was incubated overnight at 4 
ºC, followed by copious washing with surfactant Tween-20 and PBS, in order to 
remove unattached rGO 5. 
 
Figure 16. Covalent immobilization of rGO 5 on modified ITO surface with electrografted 
PNSA. 
The attachment of rGO was confirmed by SEM. The SEM images showed 
microscopic sized granules on the surface of the electrode (Figure 17). These 
microscopic granules are formed by aggregation of several rGO layers. 
 
Figure 17. SEM images of rGO 5 on modified ITO surface. 
Functionalization of graphene derivatives 
 
 
109 
SEM images evidenced the covalent attachment of rGO 5 to the electrografted 
polymer on the surface of the ITO electrode, proving that free amino groups 
were reactive. We were also able to attach antibodies to the introduced 
maleimide groups, demonstrating that we could obtain a difunctional material 
with only one functionalization of rGO. However, this material could not be used 
for the biosensor device due to the low number of antibodies introduced. We 
thought that we were introducing a low number of maleimide groups with a 
partial coverage of deprotected amino groups with the maleimidic derivative. 
3.3.2. One-pot difunctionalization of reduced graphene 
oxide 
As described in the previous chapter, difunctionalization of DWCNTs through 
radical addition with two different functional groups led to a material with 
enough antibodies and free amino groups for our purpose. Therefore, extending 
that procedure to rGO could overcome the problem of the low functionalization 
with antibodies obtained in the previous approach (section 3.3.1). Moreover, to 
the best of our knowledge, one-pot difunctionalization of graphene derivatives 
has not been described in the literature, making this approach a very interesting 
path to achieve a difunctional nanomaterial for biosensing applications. 
The followed procedure was very similar to that described for the one-pot 
difunctionalization of DWCNTs. The modification of rGO was performed (Figure 
18), as described in detail in section 2.3.2. In this section, characterization 
results will be shown and commented. 
This work was carried out using rGO purchased from Graphenea Inc. which will 
be denoted along this text as rGO 6. The main advantages of using this 
commercially available material are the higher stability of the suspension and 
the homogeneity among different batches. 
In summary, a one-pot double radical addition was performed using anilines 9 
and 11. Then, phthalimide group was removed with hydrazine monohydrate. 
Subsequently, the maleimidic group was introduced and finally Boc group 
cleavage was carried out. In addition, to avoid the partial coverage of amino 
groups, as described in previous section, the coupling of rGO 8 with compound 
13 was performed twice. 
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Figure 18. One-pot difunctionalization of rGO and modificiation of functional groups 
introduced. 
The functionalization of rGO 6 with anilines 9 and 11 was confirmed by the 
bigger weight loss in TGA at 500 ºC for rGO 7 (Figure 19). The TGA profile for 
rGO 7 presented a 6.2 % more of weight loss than rGO 6. In the same way as 
difunctionalized DWCNTs 6 in one-pot method, we cannot calculate an accurate 
FD for rGO 7, since it presents two different functional groups, but if we 
suppose that both moieties have been equally introduced, we can calculate an 
approximate FD of 169 µmol/g. The FD of free amino groups calculated by KT of 
all the compounds are displayed in Table 1. The increase of the KT value for rGO 
8 and the subsequent decrease for rGO 9 confirmed the success removing 
phthalimide group and incorporating maleimide function, respectively. 
However, after deprotection of Boc group with hydrochloric acid, KT value did 
not significantly increase. 
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Table 1. Characterization data of KT and TGA. 
Sample 
KT value 
(µmol/g) 
Weight loss (%) 
at 500 ºC in TGA 
Functionalization 
degree (µmol/g) 
rGO 6 16 11.8 - 
rGO 7 30 18.0 169 
rGO 8 118 - - 
rGO 9 66 - - 
rGO 10 68 - - 
 
Figure 19. TGA profiles for rGO 6 (black) and rGO 7 (green). 
In conclusion, even though this approach worked for DWCNTs, we did not 
obtain an equal functionalization with each aniline in rGO. KT results after 
deprotection of phthalimide and Boc groups suggest that we obtained a much 
higher functionalization with compound 9 than with compound 11. This could 
be caused by a difference in reactivity between these anilines. Probably, the 
higher reactivity for aniline 9 is consequence of π-π interactions between the 
phthalimide group and the aromatic region of rGO. This particular interaction 
could help the reaction between the generated aryl radicals and the rGO, 
making more likely the addition of a radical derived from aniline 9 than a radical 
generated from aniline 11. 
This approach did not afford a material valid for developing the biosensor 
device. The unexpected different reactivity for the aryl radicals generated from 
9 and 11 on rGO resulted in a difunctionalized graphene derivative with unequal 
functionalities. This experimental result is not in agreement with the reactivity 
observed with DWCNTs. In conclusion, a different way to obtain a 
difunctionalized material was necessary. 
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3.3.3. Non-competitive difunctionalization 
One-pot difunctionalization of rGO was not successful due to the different 
reactivity of aryl radicals. In order to overcome this problem, we designed a 
difunctionalization in two different steps, performing two non-competitive 
reactions: an addition to the basal plane and an amidation of carboxylic groups. 
In this way, the presence of one functional group will not affect the introduction 
of the next one. 
For this approach, the selected reaction was the addition of cysteamine 
hydrochloride (19, Figure 20) to GO.32 This reaction allows to introduce primary 
amino groups without a protecting group, reducing the number of total 
synthetic steps. 
Functionalization of GO with 19 was performed, as shown on Figure 20, using 
2,2-azobis(2-metylpropionitrile) (AIBN) as radical initiator. However, the use of 
this reagent at high temperature also induced the addition of azo-radicals 
generated by its thermal decomposition.33 In a second step, a basic treatment 
with NaOH led to the deprotonation of the introduced amino groups. 
 
Figure 20. Reaction of GO with cysteamine hydrochloride. 
The obtained sample was characterized by KT, TGA and XPS. The KT afforded a 
FD with primary amino groups of 216 µmol/g, confirming high yield in the 
addition of cysteamine. However, TGA (Figure 21) showed an unexpected 
profile when compared to GO. The most characteristic difference was the 
disappearance of the high weight loss between 150 and 300 ºC, corresponding 
to the thermal degradation of typical oxygenated groups of GO. This result 
suggested that those oxygenated groups had been removed during the reaction. 
In conclusion, we performed an in situ reduction of GO, mediated by the thiol 
groups of the cysteamine, in a similar way to the described reduction of GO with 
cysteine.34 
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Figure 21. TGA characterization of GO (black) and rGO 11 (orange). 
In order to confirm this reduction, XPS experiments were performed. The XPS 
spectra are showed on Figure 22 and the obtained data is displayed on Table 2. 
The lower atomic percentage in oxygen of rGO 11 was the first result that 
suggested the reduction of GO during the reaction. Moreover, the 
deconvolution of the C1s and O1s peaks showed a much lower contribution of 
the C-O (FWHM = 286.15 eV, 8.13 %) and C=O (FWHM = 287.85 eV, 5.74 %) 
components in rGO 11 than the contribution of the C-O (FWHM = 286.44 eV, 
30.61 %) and C=O (FWHM = 288.37 eV, 5.35 %) components in GO. Besides, the 
appearance of the π-π* component in the C1s peak also demonstrates the 
success in this reduction (Figure 23). In addition, the increase of sulfur and 
nitrogen percentages were another confirmation of the functionalization with 
cysteamine. Probably, the residual amount of sulfur and nitrogen in GO are 
caused by using the acid mixture of HNO3 and H2SO4 in the process of obtaining 
GO through acidic oxidation of graphite. Corresponding peaks of sulfur and 
nitrogen and their components are displayed on Figure 23E and F, respectively. 
 
Figure 22. XPS characterization for GO (black) and rGO 11 (orange). 
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Figure 23. Elemental characterization obtained from XPS experiments. Grey dots 
represent the experimental points, black and orange solid lines represents the fitting for 
the corresponding element of GO and rGO 11, respectively. The represented elements 
are A) C1s and B) O1s of GO. C) C1s, D) O1s, E) S2p and F) N1s of rGO 11.  
A) 
F) 
B) 
C) D) 
E) 
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Table 2. XPS experimental data of GO and rGO 11. The atomic % and the binding energy 
of the fitting components of the deconvolution of peaks are presented. [a] A 
deconvolution for N1s and S2p of GO could not be performed due to the low intensity of 
the peaks. 
Sample Core 
Fitting 
components 
Atomic % of fitting 
components 
Binding 
energy (eV) 
GO 
C1s 
C=C 31.38 284.37 
C=O 5.35 288.37 
C-O 30.61 286.44 
O1s O=C 5.80 531.06 
O-C 24.81 532.35 
N1s -[a] 0.56 401.21 
S2p -[a] 1.49 169.26 
rGO 11 
C1s 
C=C 58.31 284.37 
C=O 5.74 287.85 
C-O 8.13 286.15 
π-π* 4.12 289.95 
O1s O=C 7.77 531.11 
O-C 6.23 532.86 
N1s N-C 3.69 399.67 
S2p 
S-C (S2p3/2) 3.26 163.39 
S-C (S2p1/2) 1.63 164.57 
S-Ox (S2p3/2) 0.74 166.91 
S-Ox (S2p1/2) 0.37 168.09 
 
In conclusion, KT and XPS confirmed the introduction of cysteamine, presenting 
free amino groups. Moreover, TGA and XPS confirmed that GO was reduced 
during this reaction process. 
Due to the functionalization with cysteamine, we have been able to introduce 
free amino groups in one synthetic step, without requiring a deprotection. Thus, 
we could perform the amidation with maleimide derivative 13 without 
additional steps. The coupling with compound 13 was carried out as described 
before (Figure 24), obtaining rGO 12. This material afforded a KT value of 87 
µmol/g. The decrease in number of free amino groups compared to rGO 11, 
confirms the success of this reaction. Subsequently, the second functionalization 
was performed on the carboxylic groups that are present in rGO. We selected 
the Boc-monoprotected diamine 3 (Figure 24) for the amidation because Boc 
group can be easily removed by acidic treatment, affording primary amino 
groups for the attachment to the electrode surface. In addition, the introduction 
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of an oxygenated alkyl chain can enhance the solubility of rGO in water. The 
amidation coupling was carried out using 1-hydroxybenzotriazole (HOBt) and 
EDC as coupling agents, producing rGO 13 (Figure 24).7c The success of this step 
was confirmed by TGA (Figure 25). The obtained rGO 13 presented a weight loss 
of 25.2 %, which corresponds to a 2.2 % more than rGO 12. FD obtained by TGA 
corresponds to 89 µmol/g, a low value, as expected by the low area of the 
components of carboxylic groups observed by XPS analysis, corresponding to 
the low areas of C=O component at 288 eV of C1s and the O=C at 531 eV of O1s. 
 
Figure 24. Coupling with compound 13, amidation with monoprotected diamine 3 and 
deprotection of amines. 
 
Figure 25. TGA profiles of rGO 12 (light red) and rGO 13 (dark red) 
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Finally, sample rGO 14 was obtained after removal of Boc groups by acidic 
treatment with hydrochloric acid in 1,4-dioxane. KT value obtained was 199 
µmol/g. This KT value confirmed the presence of a high number of amino 
groups. Therefore, rGO 14, containing both maleimidic functional groups and 
primary amines is a good candidate for specifically linking the corresponding 
antibody 7E11c. The attachment of antibody 7E11c was then performed in a 
similar way as described in section 3.3.1 affording the rGO 15 (Figure 26). 
 
Figure 26. Attachment of antibody 7E11c, affording rGO 15. 
The obtained rGO 15 was stored as a dispersion of the Ab-functionalized rGO in 
PBS. A small fraction was dialyzed in pure water, in order to remove PBS salts 
and perform TGA. The obtained TGA profile is displayed in Figure 27, where a 
high weight loss can be observed, caused by the functionalization with a 
molecule with high molecular weight. Thus, rGO 15 presented a weight loss a 
33.8 % higher than rGO 14 at 500 ºC, corresponding to a FD of 2.3 µmol/g. 
 
Figure 27. TGA profiles of rGO 14 (pink) and antibody-functionalized rGO 15 (purple). 
In conclusion, we obtained a difunctional material with a high number of 
primary amino groups and a high functionalization with antibody 7E11c (2.3 
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µmol/g) by performing two functionalization approaches in different reactive 
points of a graphene derivative (basal plane and carboxylic groups). Therefore, 
the difunctional material rGO 15 is a good candidate to be used in the biosensor 
device. 
3.3.4. Non-covalent functionalization of CVDG 
All the functionalization studies described until now involved the use of highly 
defected graphene derivatives, as rGO. The high number of defects present in 
rGO affects to its electronic properties, which will play an important role in ECL 
production in the desired ECL biosensor. However, there are other graphene 
derivatives (i.e. nanographene obtained by molecular assembly, graphene 
obtained by mechanical exfoliation, epitaxial graphene...), but they imply high 
prices of production.35 Among the different graphene derivatives, CVDG is the 
most suitable graphene material for electronic applications, considering quality 
and price of production. For this reason, we decided to prepare a modified 
electrode based on functionalized CVDG in order to manufacture a highly 
improved ECL biosensor. 
ITO was selected as substrate for CVDG, since it will act as both substrate for 
CVDG and as transparent electrode in the biosensor device. CVDG on ITO 
(ITO/CVDG)i was produced by Graphenea Inc. The received material was 
characterized by Raman spectroscopy (Figure 28), showing a sharp and 
symmetric 2D band, which corresponds to the presence of monolayer graphene. 
In addition, D band has a low intensity compared to G band (ID/IG = 0.2), 
corresponding to a graphene with small amount of defects.36  37 
 
Figure 28. Raman spectrum of ITO/CVDG. Intensity has been normalized to the 2D peak. 
                                                          
i
 Nomenclature S/G adapted from Koehler et al. 2013,
37
 where “S” stands for substrate 
and “G” for graphene derivative. 
1000 1500 2000 2500 3000
0,0
0,2
0,4
0,6
0,8
1,0
N
o
rm
a
liz
e
d
 i
n
te
n
s
it
y
 (
a
.u
.)
Raman shift (cm
-1
)
 ITO/CVDG
D
G
2D
Functionalization of graphene derivatives 
 
 
119 
Moreover, non-covalent functionalization is an effective way to modify 
graphene without introducing new defects, thus maintaining its excellent 
electronic properties. The binding of pyrene moieties through π-stacking was 
selected because of the simplicity and the versatility of the method. With the 
objective of introducing a functional group which can act as target point for the 
attachment of the antibody, organic compound 23 (Figure 29), containing 
pyrene and maleimide moieties, was synthesized. For this purpose, the 
amidation of 1-pyrenecarboxylic acid (20) with Boc-monoprotected diamine 3 
was performed. Then, after the deprotection of Boc group by acid treatment of 
21, compound 23 was obtained by the amidation coupling with 13. 
 
Figure 29. Synthetic route for compound 23, containing pyrene and maleimide groups. 
The non-covalent functionalization of ITO/CVDG was performed through a 
simple methodology by the immersion of pristine-ITO/CVDG in a solution of 23 
in DMF (Figure 30).38 In this way, ITO/CVDG 1 was obtained after 3 hours of 
submersion. 
 
Figure 30. Non-covalent functionalization of ITO/CVDG through pyrene adsorption. 
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However, we found a great challenge in the characterization of the obtained 
functionalized ITO/CVDG. First of all, the use of a monolayer of graphene 
supported on a substrate limits the characterization techniques that can be 
used. In addition, the non-covalent functionalization does not introduce 
structural changes in graphene layers, and for this reason, Raman spectroscopy 
did not show any changes in the samples after reaction. The characterization of 
the sample was based on XPS. Since N was not present at pristine-ITO/CVDG, 
the appearance of the N1s peak at 400 eV (Figure 31) after the reaction 
suggested the adsorption of the pyrene derivative 23. 
 
Figure 31. N1s peak at 400 eV for ITO/CVDG 1. Dots represent the experimental data, 
solid line represents the fitting. 
Due to the poor characterization for the non-covalent functionalization of 
ITO/CVDG with 23, we decided to prepare a similar pyrene derivative with an 
active functional group in amperometric studies. Thus, we could confirm the 
attachment of the aromatic molecule on graphene and study the stability of the 
functionalized material under the conditions of the measurements of the 
envisioned ECL biosensor. For this purpose, organic compound 25 (Figure 32A), 
containing a ferrocenyl group, was synthesized. The ferrocenyl group was 
selected because it can be easily detected by cyclic voltammetry (CV) 
measurements, thanks to its characteristic redox behaviour. Consequently, 
ITO/CVDG was non-covalently functionalized with compound 25 (Figure 32B) 
with the same procedure used for ITO/CVDG 1. 
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Figure 32. A) Synthesis of 25, containing pyrene and ferrocenyl groups. B) Non-covalent 
functionalization of ITO/CVDG through pyrene adsorption with ferrocene-containing 
molecule. 
Subsequently, the sample was analyzed by XPS (Figure 33, Table 3). In this case, 
the employed pristine-ITO/CVDG presented a small amount of N. However, the 
N/C ratio increased from 0.022 in pristine-ITO/CVDG to 0.033 in ITO/CVDG 2. 
This increase in N percentage can suggest the non-covalent binding of the 
pyrene derivative. 
 
Figure 33. N1s peak at 400 eV of A) pristine-ITO/CVDG and B) ITO/CVDG 2. The dots 
represent the raw experimental data, the solid line represents the fitting of the data. 
Moreover, the presence of the ferrocenyl group was successfully confirmed by 
the detection of the reversible oxidation of ferrocene to ferrocenium cation at 
0.38 V in CV measurements (Figure 34, black trace). Hence, we could confirm 
the non-covalent attachment of pyrene through π-stacking with the ITO/CVDG. 
However, the current rapidly decreased after the first cycle. The reason for that 
is the diffusion of the pyrene derivative into the solution; in fact, in the second 
cycle, the ferrocene peak was not present. For this reason, the non-covalent 
functionalization of ITO/CVDG by adsorption of pyrene was abandoned at this 
A) B) 
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point for the construction of the biosensor device, since for ECL production, 
higher potentials are required. 
Table 3. XPS experimental data of p-ITO/CVDG and ITO/CVDG 2. The component O-M is 
due to the presence of ITO. [a] The percentage of C, O and N that is present exclusively 
from the CVDG sample was corrected taking into account the atomic % of O-M due to 
the ITO. 
Sample Core 
Corrected 
atomic % 
of CVDG[a] 
Fitting 
components 
Atomic % of 
fitting 
components 
Binding 
energy 
(eV) 
P-ITO/CVDG 
C1s 75.2 
C=C 54.17 284.37 
C=O 2.24 288.76 
C-O 1.25 286.60 
O1s 23.1 
O-M 23.36 530.04 
O=C 12.68 531.5 
O-C 5.02 532.78 
N1s 1.7 N-C 1.29 400.06 
ITO/CVDG 2 
C1s 75.6 
C=C 52.52 284.37 
C=O 2.84 288.39 
C-O 3.32 286.28 
O1s 21.9 
O-M 22.4 529.96 
O=C 12.39 531.58 
O-C 4.6 533.02 
N1s 2.5 N-C 1.93 399.8 
 
 
Figure 34. CV measurements of p-ITO/CVDG (red) and ITO/CVDG 2 (black, a  b: first 
cycle, b  c: second cycle). Scan rate: 10 mV/s.  
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3.4. Conclusions 
In this chapter, different approaches for the functionalization of rGO have been 
described. As consequence, different results were obtained with each method. 
Firstly, the partial coverage of primary amino groups introduced in one 
functionalization step for the obtaining of a difunctional rGO was performed. 
The desired difunctional material was successfully obtained. However, the FD 
with anti-PSMA antibody was too low and could not be used for the biosensor 
device. 
The second approach consisted on the one-pot difunctionalization of rGO with 
aryl radicals containing differently protected amino groups. This approach was 
not valid, since the different aryl radicals showed different reactivity resulting in 
an unequal functionalization. 
Next, the non-competitive difunctionalization of GO with in situ reduction to 
rGO was a successful method which afforded a material containing a high 
functionalization with anti-PSMA antibody and primary amino groups. This final 
material containing 2.3 µmol/g of antibody was an excellent candidate for the 
building of the biosensor device. 
Finally, a first approach for the non-covalent functionalization of CVDG 
supported on a substrate was studied. However, although we succeeded in 
performing this functionalization, the obtained material was not suitable for the 
biosensor device because non-covalent functionalization obtained was not 
stable under the necessary conditions for the performance of the biosensor. 
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3.5. Experimental details 
3.5.1. Materials and techniques 
Chemicals 
All the purchased chemicals and solvents were used as received without further 
purification. 
Raman spectroscopy 
Raman spectra were collected with an Invia Renishaw micro-spectrometer 
(100x) and a laser source at 532 nm. Solid samples on glass slide were measured 
without further preparation. At least 5 different points were measured on each 
sample, obtaining final spectra as the average of every single spectrum. 
TGA, KT and UV-Vis spectroscopy. 
These techniques were performed as described in section 2.5.1 in Chapter 2. 
SEM 
SEM measurements were carried out with a SEM- LEICA STEREOSCAN 430i 
microscope. Images were acquired collecting secondary electrons. Accelerating 
voltages of 10.00 kV were used. 
XPS 
XPS experiments were performed in a SPECS Sage HR 100 spectrometer with a 
non-monochromatic X-ray source of Magnesium with a Kα line of 1253.6 eV 
energy and 250 W. The samples were placed perpendicular to the analyzer axis 
and calibrated using the 3d5/2 line of Ag with a full width at half maximum 
(FWHM) of 1.1 eV. An electron flood gun was used to compensate for charging 
during XPS data acquisition. The selected resolution was 30 and 15 eV of Pass 
Energy and 0.5 and 0.15 eV/step for the survey and high resolution spectra, 
respectively. Measurements were made in an ultra-high vacuum (UHV) chamber 
at a pressure below 8·10-8 mbar. Fitting of the XPS data were done using 
CasaXPS 2.3.16 PR 1.6 software. For our data, the Shirley-type background 
subtraction was used and all curves were defined as 30% Lorentzian, 70% 
Gaussian. Atomic ratios were computed from experimental intensity ratios and 
normalized by atomic sensitivity factors. 
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3.5.2. Synthesis of organic compounds 
Synthesis of tert-butyl (2-(2-(2-(pyrene-1-
carboxamido)ethoxy)ethoxy)ethyl)carbamate (21) 
 
 
1-pyrenecarboxlic acid (20, 1 g, 4 mmol) and O-(Benzotriazol-1-yl)-N,N,N′,N′-
tetramethyluronium hexafluorophosphate (HBTU, 1.5 g, 4 mmol) were solved in 
anhydrous CH2Cl2 (35 mL) under Ar atmosphere. Then, Et3N (1.7 mL, 12 mmol) 
was added at 0 ºC and the mixture was stirred at that temperature for 30 min. 
Subsequently, a solution of 3 (1.1 g, 4.4 mmol) in anhydrous CH2Cl2 (5 mL) was 
added. The resulting mixture was allowed to reach r.t. and was stirred under Ar 
atmosphere for 24 h. Then, the crude was poured into a separation funnel 
containing DI water (150 mL) and was extracted with Et2O (3 x 150 mL). The 
combined organic layer was dried with sodium sulfate and filtered. The solvents 
were removed under reduced pressure and the product was purified by column 
chromatography (SiO2; 1:1 to 2:1, AcOEt/PET). Product 21 was a white solid (1.5 
g, 79 %). 1H-NMR (500 MHz, CDCl3) : 8.51 (d, J = 9 Hz, 1H, Hpyr), 8.14 (d, J = 7.5 
Hz, 2H, Hpyr), 8.05-7.93 (m, 6H, Hpyr), 6.86 (br, 1H, NH), 4.91 (br, 1H, NH), 3.79-
3.71 (m, 4H, 2CH2), 3.61-3.54 (m, 4H, 2CH2), 3.42 (t, J = 5.3 Hz, 2H, CH2), 3.17 (d, 
J = 4 Hz, 2H, CH2), 1.35 (s, 9H, 3CH3) ppm. 
13C-NMR (125 MHz, CDCl3) : 170.2, 
156.0, 132.4, 131.1, 131.0, 130.7, 128.6, 128.5, 127.1, 126.3, 125.8, 125.7, 
124.7, 124.4, 124.4, 124.3, 79.3, 70.3, 70.1, 70.0, 40.2, 40.0, 28.4 ppm. 
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Synthesis of 2-(2-(2-(pyrene-1-carboxamido)ethoxy)ethoxy)ethanaminium 
trifloroacetate (22) 
 
 
Trifluoroacetic acid (TFA, 2.4 mL) was added to a solution of 21 (1.2 g, 2.5 mmol) 
in CH2Cl2 (2.4 mL). The mixture was stirred at r.t. overnight. Then, toluene (25 
mL) was added and the solvents were removed with reduced pressure, 
obtaining a brown oil. The crude was sonicated in Et2O for 15 min and the 
corresponding supernatant was removed. The process was repeated twice and 
after drying, the product 22 was obtained as an oil (1.2 g, 97 %). 1H-NMR (500 
MHz, CDCl3) : 8.38 (d, J = 17 Hz, 1H, Hpyr), 8.11 (t, J = 11.3 Hz, 2H, Hpyr), 7.99-
7.85 (m, 7H, Hpyr), 7.09 (br, 1H, NH), 5.79 (br, NH3
+), 3.70-3.59 (m, 4H, 2CH2), 
3.50-3.47 (m, 6H, 3CH2), 2.85 (s, 2H, CH2) ppm. 
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Synthesis of N-(2-(2-(2-(3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-
yl)propanamido)ethoxy)ethoxy)ethyl)pyrene-1-carboxamide (23) 
 
 
EDIPA (860 µL, 4.95 mmol) was added to a solution of 22 (620 mg, 1.65mmol) 
and 13 (1.3 g, 4.95 mmol) in anhydrous DMF (20 mL) at 0ºC. The miixture was 
allowed to reach r.t. and it was stirred for 3 d. The crude was poured into a 
separation funnel containing DI water (150 mL) and it was extracted with AcOEt 
(3 x 200 mL). The combined organic layer was dried with sodium sulfate and 
filtered. The solvents were removed under reduced pressure and the residue 
was purified by column chromatography (SiO2; 1:24, MeOH/CHCl3). The 
obtained product 23 was a solid (500 mg, 57 %). 1H-NMR (400 MHz, CDCl3) : 
8.32 (d, J = 7.6 Hz, 1H, Hpyr), 8.06 (t, J = 7.2 Hz, 2H, Hpyr), 7.91 (d, J = 7.6 Hz, 1H, 
Hpyr), 7.83-7.73 (m, 5H, Hpyr), 7.43 (s, 2H, Hmaleim), 7.03 (br, 1H, NH), 4.95 (br, 1H, 
NH), 3.83 (t, J = 5.2 Hz, 2H, CH2), 3.74 (t, J = 5.6 Hz, 2H, CH2), 3.61-3.57 (m, 4H, 
2CH2), 3.48-3.37 (m, 6H, 3CH2), 2.66 (t, J = 5.6 Hz, 2H, CH2) ppm. 
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Synthesis of N-(2-(2-(2-(ferroceneamido)ethoxy)ethoxy)ethyl)pyrene-1-
carboxamide (25) 
 
 
DCC (475 mg, 2.3 mmol) was added to a solution of ferrocenecarboxylic acid 
(24, 420 mg, 1.8 mmol) and NHS (270 mg, 2.3 mmol) in anhydrous THF (9 mL) 
under Ar atmosphere. The mixture was stirred at r.t. under Ar atmosphere 
overnight. Subsequently, the mixture was dropwise transferred to a solution of 
22 (900 mg, 1.8 mmol) and Et3N (320 µL, 2.3 mmol) in anhydrous THF (9 mL). 
The mixture was stirred at r.t. under Ar atmosphere overnight. Then, the crude 
was filtered on a teflon membrane (Millipore, JHWP, 0.45 µm) and the solvents 
were removed under reduced pressure. Subsequently, the residue was solved in 
CH2Cl2 and washed with water saturated with NaCl and water. The obtained 
organic layer was dried with sodium sulfate and filtered. The solvents were 
removed under reduced pressure and the product was purified by column 
chromatography (SiO2; 1:4:15 to 1:1:6, MeOH/CH2Cl2/AcOEt). Product 25 was an 
orange solid (60 mg, 6 %). 1H-NMR (500 MHz, CDCl3) : 8.6 (d, J = 9 Hz, 1H, Hpyr), 
8.22 (d, J = 7.5 Hz, 2H, Hpyr), 8.15-8.10 (m, 4H, Hpyr), 8.05-8.02 (m, 2H, Hpyr), 6.90 
(br, 1H, NH), 6.26 (br, 1H, NH), 4.73 (t, J = 2 Hz, 2H, Hferr), 4.38 (s, 2H, Hferr), 4.25 
(s, 5H, Hferr), 3.84-3.80 (m, 4H, 2CH2), 3.70-3.68 (m, 2H, CH2), 3.62-3.60 (m, 2H, 
CH2), 3.47 (t, J = 5.5 Hz, 2H, CH2), 3.31-3.28 (m, 2H, CH2) ppm.
 13C-NMR (125 
MHz, CDCl3) : 170.5, 170.3, 166.1, 132.7, 131.3, 131.2, 130.8, 128.8, 128.7, 
127.3, 126.5, 126.0, 125.9, 124.9, 124.6, 124.5, 72.2, 70.5, 70.4, 70.3, 70.1, 69.7, 
40.2, 39.4 ppm. 
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3.5.3. Graphene derivatives modification 
Synthesis of rGO 1 
 
 
TGO (200 mg) was dispersed in water (400 mL) with the aid of a sonication bath. 
Then, NH4OH solution (950 µL) and hydrazine monohydrate (136 µL) were 
added and the mixture was stirred at 95 ºC for 1 h. The suspension was dialyzed 
against DI water for 2 d. Subsequently, the black suspension was filtered on a 
teflon membrane (Millipore, GTTP, 0.1 µm) and washed by 
redispersion/filtration with DMF (3 x 100 mL) and MeOH (3 x 100 mL). Obtained 
mass: 76 mg. 
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Synthesis of rGO 2 
 
 
The rGO 1 (40 mg) was dispersed in NMP (80 mL) by sonication for 15 min. The 
aniline 9 (3.3 g, 8.3 mmol) was added and the suspension was heated to 80 ºC. 
Then, isopentyl nitrite (12, 1.7 mL, 12.5 mmol) was added dropwise to the 
reaction mixture, which was allowed to react at 80 ºC for 3 h. The suspension 
was filtered on a teflon membrane (Millipore, JHWP, 0.45 µm), and the solid 
was washed with DMF until a colorless filtrate was obtained. Afterward, the rGO 
2 was collected and redispersed in DMF (150 mL) for 5 min. The reaction 
mixture was filtered under same conditions, and the process was repeated 3 
times. This washing sequence was continued in an identical manner with 
alternating cycles of MeOH (3 x 150 mL), DI water (6 x 150 mL), MeOH (150 mL) 
and AcOEt (150 mL). Finally, the solid sample was rinsed in the filter funnel with 
Et2O and left to dry at r.t. under vacuum. Obtained mass: 39.2 mg, FD: 124 
µmol/g (TGA), 75 µmol/g (KT). 
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Synthesis of rGO 3 
 
 
Hydrazine monohydrate (1.5 mL) was added to a suspension of rGO 2 (15 mg) in 
ethanol (150 mL). The mixture was stirred at r.t. overnight. The obtained 
suspension was filtered on a teflon membrane (Millipore, JHWP, 0.45 µm), and 
washed by applying redispersion/filtration cycles with DI water (3 x 150 mL) and 
MeOH (150 mL). Finally, the sample was rinsed with Et2O and dried under 
vacuum. Obtained mass: 13.5 mg, FD: 277 µmol/g (KT). 
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Synthesis of rGO 4 
 
 
The rGO 3 (10.5 mg) was dispersed in anhydrous DMF (21 mL) by sonication for 
15 minutes while Ar was bubbled into the solvent. The maleimidic derivative 13 
(22.3 mg, 0.08 mmol) and EDIPA (37 µL, 0.2 mmol) were added and the mixture 
was stirred under Ar at r.t. overnight. The reaction suspension was filtered on a 
teflon membrane (Millipore, JHWP, 0.45 µm), rinsed with DMF and washed by 
redispersion/filtration cycles with DMF (4 x 100 mL), MeOH (3 x 100 mL), and 
finally it was rinsed with Et2O. Obtained mass: 9.5 mg, FD: 118 µmol/g (KT). 
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Synthesis of rGO 5 
 
 
The rGO 4 (3.56 mg) was added to a PBS solution (3 mL) at pH 7.2 of the 
antibody 7E11c (2.54 mg), which contains 2 SH groups per antibody. The 
solution was sonicated a few seconds in a sonication bath with ice and then it 
was gently shaken for 24 hours at 8 ºC. The mixture was diluted with fresh PBS 
at pH 7.2 to a total volume of 15 mL. Then, it was centrifuged (2000 rpm, 4 min) 
in a Vivaspine 20 centrifuge tube (300 KDa cut-off membrane). This 
centrifugation process was repeated 5 more times with fresh PBS. The pH was 
exchanged to 7.4 by dialysis in PBS for 48 hours using a 300 KDa cut-off 
membrane. After the dialysis, the product was stored at 4 ºC as a suspension 
with a concentration of 1 mg/mL in PBS. 
A fraction of this suspension was dialyzed in Milli-Q water in order to remove all 
PBS salts to perform TGA. A weight loss of 28.9 % was obtained, corresponding 
to a FD of 0.2 µmol/g. 
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Synthesis of rGO 7 
 
 
Commercially purchased rGO 6 (40 mg) was dispersed in NMP (80 mL) by 
sonication for 15 min. The anilines 9 (1.6 g, 4 mmol) and 11 (1.5 g, 4 mmol) were 
added and the suspension was heated to 80 ºC. A solution of isopentyl nitrite 
(12, 2 mL, 14 mmol) in NMP (140 mL) was added dropwise to the reaction 
mixture, which was allowed to react at 80 ºC for 3 h. The suspension was 
filtered on a teflon membrane (Millipore, JHWP, 0.45 µm), and the solid was 
washed with DMF until a colorless filtrate was obtained. Afterward, the rGO 7 
was collected and redispersed in DMF (150 mL) for 5 min. The reaction mixture 
was filtered under same conditions, and the process was repeated 3 times. This 
washing sequence was continued in an identical manner with alternating cycles 
of MeOH (3 x 150 mL), Milli-Q water (3 x 150 mL), MeOH (150 mL) and AcOEt 
(150 mL). Finally, the solid sample was rinsed in the filter funnel with Et2O and 
left to dry at r.t. under vacuum. Obtained mass: 48.21 mg, FD: 169 µmol/g 
(TGA), 30 µmol/g (KT). 
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Synthesis of rGO 8 
 
 
Hydrazine monohydrate (438 µL) was added to a suspension of rGO 7 (35 mg) in 
ethanol (175 mL). The mixture was stirred at r.t. overnight. The obtained 
suspension was filtered on a teflon membrane (Millipore, JHWP, 0.45 µm), and 
washed by applying redispersion/filtration cycles with EtOH (3 x 150 mL), DMF 
(3 x 150 mL), Milli-Q water (3 x 200 mL) and MeOH (3 x 150 mL). Finally, the 
sample was rinsed with Et2O and dried under vacuum. Obtained mass: 29.13 
mg, FD: 118 µmol/g (KT). 
Chapter 3 
 
 
136 
Synthesis of rGO 9 
 
 
The rGO 8 (20 mg) was dispersed in anhydrous DMF (40 mL) by sonication for 30 
minutes while Ar was bubbled into the solvent. The maleimidic derivative 13 (25 
mg, 0.1 mmol) and EDIPA (41 µL, 0.24 mmol) were added and the mixture was 
stirred under Ar at r.t. overnight. The reaction suspension was filtered on a 
teflon membrane (Millipore, JHWP, 0.45 µm), rinsed with DMF and washed by 
redispersion/filtration cycles with DMF (4 x 150 mL), MeOH (3 x 100 mL), and 
finally it was rinsed with Et2O. Obtained mass: 19.28 mg. 
The whole process was repeated. Obtained mass: 15.87 mg, FD: 66 µmol/g (KT). 
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Synthesis of rGO 10 
 
 
The rGO 9 (10 mg) was dispersed in 1,4-dioxane (67 mL) by sonication. Then, HCl 
(33%, 33 mL) was added and mixture was stirred at r.t. overnight. The 
suspension was filtered on a teflon membrane (Millipore, JHWP, 0.45 µm), 
rinsed with Milli-Q water and washed by redispersion/filtration with Milli-Q 
water (4 x 150 mL), DMF (3 x 100 mL), MeOH (3 x 100 mL) and rinsed with Et2O. 
Obtained mass: 7.43 mg, FD: 68 µmol/g (KT). 
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Synthesis of rGO 11 
 
 
The GO powder (50 mg) was dispersed in DMF (100 mL) by using ultrasonication 
for 30 min in three-necked round bottom flask. Nitrogen bubbling was carried 
for 30 min to introduce inert environment. Then, the cysteamine hydrochloride 
(19, 711 mg, 6.26 mmol) and AIBN (2.5 mL of 0.2 M solution in toluene) in 5 mL 
of DMF were injected to the reaction mixture. The reaction mixture was heated 
to 70 ºC and kept for 18 h. The reaction was cooled down and a solution of 
NaOH (1 M) in ethanol/water (15:5 mL) was added to the mixture while stirring. 
The mixture was stirred for 12 h. Then, crude was filtered on a teflon membrane 
(Millipore, JHWP, 0.45 µm) and washed by redispersion/filtration with DMF (3 x 
50 mL) DI water (3 x 100 mL), and EtOH (3 x 100 mL) and rinsed with Et2O. 
Obtained mass: 34 mg, FD: 216 µmol/g (KT). 
Synthesis of rGO 12 
 
 
The rGO 11 (29 mg) was dispersed in anhydrous DMF (58 mL) by sonication for 
30 minutes while Ar was bubbled into the solvent. The maleimidic derivative 13 
(67 mg, 0.25 mmol) and EDIPA (110 µL, 0.63 mmol) were added and the mixture 
was stirred under Ar at r.t. overnight. The reaction suspension was filtered on a 
teflon membrane (Millipore, JHWP, 0.45 µm), rinsed with DMF and washed by 
redispersion/filtration cycles with DMF (4 x 150 mL), MeOH (3 x 100 mL), and 
finally it was rinsed with Et2O. Obtained mass: 26.04 mg, FD: 87 µmol/g (KT). 
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Synthesis of rGO 13 
 
 
The rGO 12 (21 mg) was dispersed in DMF (210 mL) by sonication for 20 min 
while Ar was bubbled into solvent. Bubbling was continued for 10 min and the 
mixture was cooled to 0 ºC. Then, HOBt (473 mg, 3.5 mmol) and EDC (671 mg, 
3.5 mmol) were added. The resulting mixture was stirred at 0 ºC for 1 h. Then, a 
solution of 3 (434 mg, 1.75 mmol) and 4-dimethylaminopyridine (DMAP, 427 
mg, 3.5 mmol) in DMF (10 mL) was added and the mixture was allowed to reach 
r.t. and stirred for 48 h. The suspension was filtered on a teflon membrane 
(Millipore, JHWP, 0.45 µm), rinsed with DMF and washed by 
redispersion/filtration cycles with DMF (4 x 150 mL), MeOH (3 x 150 mL), Milli-Q 
water (3 x 150 mL), MeOH (150 mL), AcOEt (150 mL) and finally it was rinsed 
with Et2O. Obtained mass: 19.7 mg, FD: 89 µmol/g (TGA), 147 µmol/g (KT). 
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Synthesis of rGO 14 
 
 
The rGO 13 (12 mg) was dispersed in 1,4-dioxane (81 mL) by sonication. Then, 
HCl (33%, 39 mL) was added and mixture was stirred at r.t. overnight. The 
suspension was filtered on a teflon membrane (Millipore, JHWP, 0.45 µm), 
rinsed with Milli-Q water and washed by redispersion/filtration with Milli-Q 
water (4 x 150 mL), DMF (3 x 100 mL), MeOH (3 x 100 mL) and rinsed with Et2O. 
Obtained mass: 10.14 mg, FD: 199 µmol/g (KT). 
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Synthesis of rGO 15 
 
 
The rGO 14 (1.4 mg) was added to a PBS solution (1.6 mL) at pH 7.9 of the 
antibody 7E11c (1 mg), which contains 2 SH groups per antibody. The solution 
was sonicated 10 min in a sonication bath with ice and then it was gently shaken 
for 24 hours at r.t. The mixture was diluted with fresh PBS at pH 7.9 to a total 
volume of 15 mL. Then, it was centrifuged (2500 rpm, 5 min) in a Vivaspine 20 
centrifuge tube (300 KDa cut-off membrane). This centrifugation process was 
repeated 7 more times with fresh PBS. The pH was exchanged to 7.4 by dialysis 
in PBS for 48 hours using a 300 KDa cut-off membrane. After the dialysis, the 
product was stored at 4 ºC as a suspension with a concentration of 0.56 mg/mL 
in PBS. 
A fraction of this suspension was dialyzed in Milli-Q water in order to remove all 
PBS salts to perform TGA. A weight loss of 56.3 % was obtained, corresponding 
to a FD of 2.3 µmol/g. 
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Synthesis of ITO/CVDG 1 
 
 
Pristine-ITO/CVDG was fully immersed in a solution of 23 (9.6 mg) in DMF (5 mL) 
at r.t. for 3 h. Then, the substrate was washed by submersion followed by drying 
with a N2 stream in DMF (3 x 10 mL) and Milli-Q water (3 x50 mL). 
Synthesis of ITO/CVDG 2 
 
 
Pristine-ITO/CVDG was fully immersed in a solution of 25 (10 mg) in DMF (5 mL) 
at room temperature for 3 h. Then, the substrate was washed by submersion in 
fresh DMF (4 x 20 mL) and Milli-Q water (4 x 20 mL). 
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Chapter 4 
CNMs-based biosensor for 
the detection of PSMA  
 
4.1. Introduction 
Prostate cancer is the second cause of death from cancer among men. However, 
an early detection at first stages highly increases the survival ratio. Because of 
this reason, the development of new devices for the detection of cancer 
biomarkers is extremely important. 
The most important cancer biomarker for prostate cancer is prostate-specific 
antigen (PSA), since the detection of this protein is actually used nowadays for 
clinical diagnosis of this disease. However, serum PSA has a low specificity 
because it is not exclusively an event related to prostate cancer, elevated levels 
can also be detected in men with benign prostatic hyperplasia (BPH) and 
prostatitis.1 Thus, more accurate tests are needed in order to avoid false 
positives. Many biomarkers have been identified and some of them are 
promising due to their specificity for the disease in tissue. However, tissue is 
unsuitable as substrate for biomarker testing because of its invasiveness and 
expensiveness. Therefore, testing of disease-related biomarkers in body fluids 
that can be obtained in a non-invasive manner seems a good alternative as a 
possible screening tool. 
Prostate-specific membrane antigen (PSMA) is a glycoprotein expressed in the 
prostatic epithelium endowed with enzymatic activity.2 This protein is strongly 
over-expressed in prostate tumor cells and, unlike other typical prostate-specific 
antigens like PSA, is an extracellular target. In addition, the average serum 
PSMA levels for prostate cancer patients are significantly higher compared to 
those of men with BPH and healthy controls.3 These findings implicate that 
serum PSMA is suitable to distinguish men with BPH from prostate cancer 
patients, indicating that PSMA is a very promising diagnostic marker.4 
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In this context, biosensors play an important role in the detection of cancer 
biomarkers in cancer diagnosis. As mentioned in the general introduction in 
Chapter 1, immunosensors, based on the highly specific molecular recognition 
between immobilizing antibody and antigen, are the most prominent biosensors 
in clinical analysis.5 There are different types of transduction techniques that are 
used for the construction of immunosensors. Among them, 
electrochemiluminescence (ECL) has been proven to be the pivotal detection 
methodology. The electrochemical way to generate the excite state allows to 
combine simple instrumentation, high sensitivity and versatility, low-cost 
method and wide concentration response.6  
Nowadays, nanotechnology is contributing to improve ECL sensors by using 
nanomaterials as electrical components of transducers that connect electrode 
and redox centre or as novel ECL components.7 In particular, CNTs and graphene 
derivates play a fundamental role in this fields thanks to the low overpotential 
for the co-reactant oxidation, which is the rate determining step in the ECL 
signal generation.8 
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4.2. Aim of the work 
In this chapter, the manufacturing and performance of different ECL 
immunosensors for the detection of PSMA in cell lysates will be described. For 
this purpose, two different CNMs functionalized with anti-PSMA antibody 
(Figure 1) were used: DWCNTs and oxidized MWCNTs (ox-MWCNTs). The 
synthesis and characterization of these CNTs have been fully described on 
Chapter 2.  
Herein, a general procedure for the building of the ECL immunosensor will be 
described. Following, a comparison of the results obtained with the two 
different materials will be detailed. 
 
Figure 1. CNTs used for the preparation of an ECL immunosensor for the detection of 
PSMA. 
All the work presented in this chapter has been performed in collaboration with 
the group of Prof. Francesco Paolucci at University of Bologna. 
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4.3. Results and discussion 
The building of an ECL immunosensor for PSMA detection was performed with 
different CNMs. The described procedure can be applied to any CNM which 
contains primary amino groups and the anti-PSMA 7E11c antibody. Thus, to 
avoid repetition, a general procedure for any CNM is firstly described and then, 
the different results with the different CNTs employed will be displayed. 
4.3.1. General procedure for the immunosensor assembly 
The procedure followed for the preparation of the immunosensor involved 
several steps: the immobilization of the CNM on the modified surface of ITO 
electrode, the subsequent blocking of free binding sites, the incubation with 
PSMA, the incubation with the detection moiety and the ECL production. 
Firstly, the surface of a transparent ITO electrode was modified with an 
electrochemically grown layer of N-succinimidyl polyacrylates (PNSA), as shown 
on Figure 2.9 The main reason for using N-succinimidyl acrylate (NSA, 18) as a 
monomer is the presence of activated ester groups that give a high reactivity to 
nucleophiles, which, in turn, lead to the functionalization of this substrate with 
the dispersed CNMs in PBS solution (Figure 2). Although this polymer is 
electrically insulating, previous experiments with ferrocene-functionalized CNTs 
have demonstrated that PNSA-coated ITO is still electroactive.10 
 
Figure 2. Modification of the surface of ITO through polymerization of NSA and 
subsequent immobilization of a general CNM which possesses anti-PSMA antibody and 
primary amino groups. 
For this process, the polymerization was induced by CV scanning the potential 
until the first reduction of the monomer at -2.1 V. The formation of the 
chemisorbed insulating film was accompanied by a decrease of the cathodic 
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current, and the best performance of the polymer deposition was obtained 
when the final current decreased the 40 % of the initial one. Subsequently, the 
corresponding CNM, which is covalently functionalized with the 7E11c antibody, 
was anchored onto the electrografted polymer (Figure 2). The CNM-7E11c 
conjugate, dispersed in PBS, was deposited onto the electrode in the presence 
of coupling agent EDC and incubated overnight at 4 ºC.i 
Afterwards, the free antibody binding sites of the sensor surface were blocked 
with a milk solution,ii followed by washing with a detergent Tween-20 buffer. 
The inhibition of free binding sites is crucial to control the stability and 
reproducibility of the immunosensing interface among analogous electrodes 
and to achieve high sensitivity and low detection limits.  
Moreover, the washing procedure is also very important because non-bound on 
the electrode are removed after the treatment with the detergent. After that, 
the assembly was incubated with a lysate at different PSMA concentrations for 
two hours (Figure 3). The PSMA samples were diluted in PSMA-free lysate. 
 
Figure 3. General scheme for the assembly and ECL signal production of the CNM-based 
biosensor. 
                                                          
i
 In these conditions, we cannot discard the direct immobilization of the primary amino 
groups present on the antibody. 
ii
 Non-fat milk is one of the most common blocking agents used for Western blots. It 
contains a variety of proteins found in milk. 
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Finally, the system was exposed to the detection moiety (Figure 3). Two 
different detection moieties have been used in this work. Both were composed 
by the anti-PSMA antibody D2B and the electrochemiluminescent probe 
[Ru(bpy)3]
2+ in different proportions. 
The ECL detection was carried out in an open cell (Figure 4), containing 200 mM 
of co-reactant tripropylamine (TPA) in a solution of PBS 0.2 M. The ECL signal 
was obtained by pulsing the working electrode potential between 0.0 V and 1.7 
V vs Ag/AgCl. Such a high potential (1.7 V) is necessary because of the presence 
of the insulating layer of PNSA. Consequently, the application of this potential 
led to the generation of a TPA cationic radical (as explained in the general 
introduction, the direct oxidation of the [Ru(bpy)3]
2+ probe is discarded), which 
partly undergoes a deprotonation reaction, which lead to a highly reducing 
radical specie. Both TPA radical and radical cation coexist in the proximity of the 
electrode and thus they react with the luminophore. In this way, through a 
simple potential step, the excited state, [Ru(bpy)3]
2+*, is generated. The intensity 
of the ECL response is proportional to the concentration of the [Ru(bpy)3]
2+ 
probe and, consequently, to the amount of PSMA on the sensor surface. All 
experiments were repeated several times in order to verify the stability of the 
measured ECL signal. 
 
Figure 4. Side, up and bottom view of the open cell for ECL detection. The arrows point 
the ITO electrode, held between the Teflon and the metallic parts of the cell. 
4.3.2. ECL measurements with ox-MWCNTs 
The first approach for the assembly of the biosensor was carried out using as 
capture probe ox-MWCNTs 7 (see Chapter 2), which contained 3 mol of 7E11c 
antibody per g of CNTs. The used detection moiety consisted on the monoclonal 
antibody D2B covalently linked to a [Ru(bpy)3]
2+ complex through a butyl chain 
(D2B-Ru, Figure 5). This conjugate was easily obtained by an amidic coupling of 
the amine-substituted Ru complex 26 with the activated carboxylic acids 
naturally present in the antibody structure (Figure 5). 
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Figure 5. Preparation of detection moiety D2B-Ru by amidic coupling between D2B 
antibody and amine-substituted Ru complex 26. 
Following the described procedure, ox-MWCNTs 10 were first immobilized on 
the modified surface of ITO, subsequently incubated with varying 
concentrations of PSMA and finally incubated with detection moiety D2B-Ru 
(Figure 6). 
 
Figure 6. Schematic representation of biosensor assembled with ox-MWCNTs 7. 
Firstly, the immobilization of the ox-MWCNTs 7 on the modified surface of ITO 
electrode was confirmed by SEM (Figure 7). The presence of agglomerates 
composed by CNTs on the surface of ITO observed on SEM images confirmed 
the success of the coupling of ox-MWCNTs 7 to the electrografted polymer. 
Chapter 4 
 
 
152 
 
 
Figure 7. SEM images of agglomerates of CNTs on the surface of ITO electrode. 
Subsequently, after the addition of co-reactant TPA, ECL was obtained. Figure 8a 
shows typical amperometric and ECL signals measured during an experiment 
with the assembled immunosensor for 3.6 ng/mL of PSMA. ECL was obtained by 
pulsing the working electrode potential between 0.0 V (1 s) and 1.7 V (4 s) and 
recording simultaneously the current at the ITO substrate (black trace) and the 
ECL intensity (red trace) (Figure 8a). The current measured upon the application 
of the oxidation potential, following a typical Cottrellian behavior,i is associated 
with the TPA oxidation, which, in turn, excites the [Ru(bpy)3]
2+ probe. In 
addition, Figure 8b shows the result of the blank experiment where the 
immunosensing surface was incubated with D2B-Ru, in PSMA-free lysate. In this 
case, although the same Cottrellian current (associated with the TPA oxidation) 
was measured at the substrate, a very low ECL signal was detected, thus 
indicating a low background signal of the immunosensor. 
                                                          
i
 The Cottrellian behavior, defined by the Cottrell equation, describes the asymmetry of 
the current peak in chronoamperometry experiments, since current is controlled by the 
diffusion process. 
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Figure 8. ECL intensity (red) and current (black) vs time from 200 mM TPA in PBS. Step 
potential E1 = 0 V, t1 = 1 s; E2 = 1.70 V, t2 = 3 s. PMT bias 750 V, amplification 00.0 nA. 
The ox-MWCNTs 7 were incubated with: a) a lysate solution containing 3.6 ng/mL of 
PSMA antigen and b) the solution of dilution (PSMA-free) for 2h. 
Different PSMA concentrations ranging from 2 to 12 ng/mL were analyzed. In all 
cases, the steady-state ECL intensity was averaged upon three subsequent 
potential steps, and the results are shown in Figure 9a. The data were analyzed 
by assuming that the ECL intensity was proportional to the PSMA concentration 
through a typical adsorption isotherm governing the antibody-antigen 
recognition equilibrium. The CNT-based biosensor shows a very large operating 
range with a linear correlation between the analytical signal and the PSMA 
concentration up to 15 ng/mL. In addition, the limits of detection (LOD) and 
quantification (LOQ) were calculated by adding to the ECL signal of the PSMA-
free control 3 and 10 times the standard deviation, respectively. By using the 
fitting equation in the linear range of analysis (Figure 9b), for the 
nanostructured biosensor, a LOD equal to 0.88 ng/mL and a LOQ of 2.60 ng/mL 
were reached. These analytical values were obtained in a real complex matrix. 
Importantly, our ECL-based biosensor responds to PSMA concentrations ranging 
in the windows of the diagnostic values.11 In fact, samples from patients 
diagnosed with prostate cancer typically express a PSMA level of 18 ng/mL for 
the PSMA-overexpressing tumors while 9 ng/mL for the non-PMSA-
overexpressing group. The biosensor presented here offers remarkable 
performance in line with the state of-the-art also in real experimental 
conditions such as cell lysates that contain different and high concentrations of 
other type of proteins.12 
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Figure 9. a) ECL intensity for different concentrations of PSMA in the presence of 180 
mM of TPA in PBS at 1.70 V. b) Linear range of ECL intensity for PSMA analysis (11.3, 
5.65, 4.50, 3.60, 2.25, 0 ng/mL). Error bars show the standard deviation (n=3). 
In order to highlight any specific role played by CNTs in the immunosensor 
performance, a second type of surface was prepared. In this case, the electrode 
modified with the electrografted polymer was directly incubated with the 
monoclonal antibody, i.e., lacking the CNT interlayer. For the preparation of this 
control immunosensor, the same experimental conditions of the ox-MWCNTs 
immunoassay were used. If detected, variations in the performance of the 
control device should be ascribed to the specific role played by the CNT 
interlayer. The Figure 10 shows that, with the immunosensor without CNTs, a 
much lower ECL signal was detected for the same range of PSMA concentrations 
(red dots). 
 
Figure 10. Comparison of ECL intensity produced by the two immunosensors: CNTs-
based immunosensor (black) and 7E11c antibody directly immobilized on electrode 
surface (red). 
In view of their well-known electrical and redox properties, the CNTs can behave 
as individual nanoelectrodes, statistically interconnected and electrically wired 
to the ITO substrate. Thanks to the ox-MWCNTs 7, the TPA oxidation process 
takes place more efficiently, thus highlighting the fundamental role played by 
the CNTs. 
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4.3.3. ECL measurements with DWCNTs 
In a second study, PSMA detection was tested using DWCNTs 10 (see Chapter 
2), containing 0.52 µmol of 7E11c antibody per gram of sample, as capture 
probe. An improvement from the ox-MWCNTs-based biosensor was expected, 
since DWCNTs did not require an oxidation for their functionalization, thus 
maintaining their sp2 character and better electronical properties. In addition, 
the covalent functionalization of DWCNTs takes place on the outer tube, while 
the inner tube remains intact, and consequently, retains the conductivity (Figure 
11).13 
 
Figure 11. Schematic representation of a DWCNT. The inner wall remains intact while 
the outer wall can be functionalized. Adapted from Brozena et al. 2010.
13
 
Firstly, DWCNTs 10 were immobilized on the modified surface of ITO, as detailed 
in section 4.3.1. As with MWCNTs, this immobilization was demonstrated by 
SEM images, where agglomerates composed of CNTs were observed (Figure 12). 
 
Figure 12. SEM images of DWCNTs 10 immobilized on the modified surface of ITO. 
Chapter 4 
 
 
156 
In a first study of the DWNCTs-based biosensor, D2B-Ru, containing a Ru 
complex per antibody, was used as detection moiety, as with ox-MWNCTs. The 
DWCNTs-based immunosensor, represented on Figure 13, was obtained as 
detailed in section 4.3.1. 
 
Figure 13. Schematic representation of the DWCNTs-based biosensor using D2B-Ru as 
detection probe. 
After the addition of a solution of 200 mM of TPA in PBS, an ECL signal was 
obtained by pulsing the working electrode potential between 0.0 V (1 s) and 1.7 
V (4 s). As shown on Figure 14a, the current at the ITO substrate (black trace) 
was simultaneously recorded with the ECL intensity (red trace). The same 
Cottrellian behavior observed for ox-MWCNTs (Figure 8) is present in this case. 
In addition, a blank experiment using PSMA-free lysate was performed, 
observing the Cottrellian current when applying the potential, but a low ECL 
production (Figure 14b), as with ox-MWCNTs. 
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Figure 14. ECL intensity (red trace) and current (black) vs time from 200 mM TPA in PBS. 
Step potential E1 = 0 V, t1 = 1 s; E2 = 1.70 V, t2 = 3 s. PMT bias 750 V, amplification 00.0 
nA. The DWCNTs 10 were incubated with: (a) a lysate solution containing 3.6 ng/mL of 
PSMA antigen and (b) the solution of dilution (PSMA free). 
Different PSMA concentrations were analyzed. In all cases, the steady-state ECL 
intensity was averaged upon three subsequent potential steps. The results are 
shown in Figure 15. Although a direct comparison with MWCNT based-sensor is 
difficult because the used concentrations were different, DWCNT-based sensor 
showed a bigger linear range with and similar LOD.  
 
Figure 15. ECL intensity for different concentrations of PSMA in the presence of TPA in 
PBS at 1.70 V. ECL experimental conditions: PMT bias 750 V, amplification 00.0 nA. Error 
bar shows the standard deviation (n=3). 
In order to obtain a better response with DWCNTs, an enhancement of ECL by 
using a different detection moiety was designed. In the previous ECL 
measurements, the conjugate D2B-Ru, containing a Ru complex per antibody, 
was used as detection moiety. In this case, a [Ru(bpy)3]
2+ per sandwich 
immunoassay was present. Subsequently, we proposed a second approach 
using magnetic Fe2O3 microbeads containing several Ru complexes and D2B 
antibodies, D2B,Ru@Fe2O3 (Figure 16). Hence, several [Ru(bpy)3]
2+ molecules 
per immunosandwich would be present, affording a higher ECL signal. 
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Figure 16. Schematic representation of D2B,Ru@Fe2O3 microbeads containing several 
D2B antibodies and Ru complexes. 
In order to obtain the D2B,Ru@Fe2O3 microbeads, streptavidin-coated Fe2O3 
beads were purchased. Due to the strong interaction between biotin and 
streptavidin, biotinated D2B antibody and [Ru(bpy)3] complex functionalized 
with biotin were used to functionalize the beads. The ECL signal of the beads in 
presence of TPA was demonstrated by recording the ECL image (Figure 17a). In 
addition, the micrometric size of the beads could be assessed (Figure 17b). 
 
Figure 17. a) ECL image and b) ECL profile from D2B,Ru@Fe2O3 and in 200 mM TPA in 
PBS. Step potential: E1 = 0 V; E2 = 1.70 V. Integration time: 4 seconds. Gain: 3. 
Sensitivity: 400. Magnification: 20x. 
Therefore, D2B,Ru@Fe2O3 microbeads were used as detection probe for the 
manufacturing of the PSMA immunosensor based on DWCNTs (Figure 18), 
following the procedure described in the section 4.3.1. The success of the PSMA 
recognition by the D2B antibody immobilized on the microbeads was confirmed 
by SEM (Figure 19). The presence of the spherical microbeads on the 
agglomerates of CNTs, after the corresponding washings, confirms the specific 
binding of the D2B antibody to the PSMA protein. 
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Figure 18. Schematic representation of the PSMA immunosensor based on DWCNTs 10 
as capture probe and D2B,Ru@Fe2O3 microbeads as detection probe. 
 
Figure 19. SEM images confirming the success of the binding of D2B,Ru@Fe2O3 
microbeads to the PSMA captured by the 7E11c antibody present on DWCNTs. 
 
 
Chapter 4 
 
 
160 
Finally, for the recording of ECL at different PSMA, 200 mM TPA in PBS was 
added and then, a potential of 1.7 eV was applied while ECL intensity and 
current at the electrode were measured (Figure 20). However, no changes in the 
ECL intensity were observed after applying the potential.  
 
Figure 20. ECL intensity (red trace) and current (black trace) vs time from 200 mM TPA in 
PBS. Step potential E1 = 0 V, t1 = 1 s; E2 = 1.70 V, t2 = 3 s. PMT bias 750 V, amplification 
00.0 nA. The DWCNTs 10 were incubated with a lysate solution containing 3.6 ng/mL of 
PSMA antigen and D2B,Ru@Fe2O3 microbeads. 
In conclusion, the microbeads containing Ab and Ru complex demonstrated they 
could undergo the production of ECL by the Ru complex (Figure 17) and the 
binding to the PSMA protein by the D2B antibody. However, they were not 
suitable for being used in the biosensor device. Probably, the reason was the 
size of the beads. Further experiments with smaller beads should be perform in 
order to confirm it. 
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4.4. Conclusions 
In this chapter, the use of difunctionalized CNTs for biosensing applications has 
been demonstrated by the construction of an ECL immunosensor for the 
detection of the prostate cancer biomarker PSMA.  
The preparation of the biosensor was described in a first experiment with 
difunctionalized ox-MWCNTs. The obtained biosensor showed good response, 
with a linear correlation between the analytical signal and the PSMA 
concentration up to 4.5 ng/mL. In addition an excellent LOD of 0.88 ng/mL and a 
LOQ of 2.60 ng/mL were calculated, allowing the detection of PSMA within the 
desired clinical window. 
Moreover, a second biosensor with difunctionalized DWCNTs was developed. 
The obtained biosensor also showed a good ECL response for different 
concentrations of PSMA. However, the results obtained with the ox-MWCNTs-
based biosensor were not improved with the DWCNTs-based biosensor. 
Finally, an attempt to enhance the generation of ECL signal was performed by 
using microbeads, which contained several Ru molecules and antibodies. In this 
case, although the microbeads showed ECL, they could not be incorporated on 
the DWCNTs-based biosensor. 
In addition, another remarkable conclusion was obtained from the experiment 
in which capture antibody 7E11c was directly immobilized in the surface of ITO, 
without CNTs. In this experiment, a much lower ECL signal than with the ox-
MWCNTs-based biosensor was obtained. Thus, the fundamental role played by 
the CNTs was demonstrated. 
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4.5. Experimental details 
4.5.1. Materials 
Chemicals 
All the chemicals and solvents purchased were used as received without further 
purification. 
Ruthenium complexes were purchased from Cyanagen Srl (Milano, Italy). 
PSMA lysates 
LNCap (PSMA+) and PC-3 (PSMA-) human prostate cancer cell lines were 
purchased from America Type Culture Collection (ATCC, Manassas, VA, USA) and 
cultured in RPMI1640 medium with 10 % of FBS (fetal bovine serum), 2 mM L-
glutamine and antibiotics. Cell lines were maintained in culture flasks at 37 ºC 
and 5 % CO2 under a humidified atmosphere. When the cells arrived at 
confluence were detached with trypsin-EDTA flasks and collected by 
centrifugation. After two washes with PBS, cells were lysed in Tris buffer 10 mM 
pH 8.0 added with EDTA 2 mM, NaCl 150 mM, 1 % NP40 and protease inhibitors 
(Sigma-Aldrich, Milan, Italy). The amount of PSMA antigen present in the cell 
lysates was quantified by an ELISA assay. 
Anti-PSMA antibodies 
7E11c hybridoma was purchased from ATCC and D2B hybridoma was previously 
produced by our colaborators at the Department of Medicine, Immunology 
Section, University of Verona, Verona, Italy; both hybridomas were grown in 
Hybridomed DIF 1000 serum free medium (Biochrom GmbH, Berlin, Germany) 
and maintained in CELLine 350 flasks (INTEGRA Biosciences AG, Zizers, 
Switzerland) at 37 ºC and 7 % CO2 under a humidified atmosphere. The two 
antibodies were purified from the cell culture supernatant by affinity 
chromatography on protein G column (GE Healthcare, Little Chalfont, GB) and 
their functionality and specificity were assessed by flow cytometry on PSMA 
positive and negative cell lines. 
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4.5.2. Synthesis of the detection probes 
Synthesis of D2B-Ru 
 
 
EDC (0.132 mg), NHS (0.1 mg), and tris(bipyridine)ruthenium complex derivative 
26 (0.8 mg) were added to 1 mL of Ab D2B solution in PBS (1.5 mg/mL), after 
correcting pH to 7.8. The mixture was shaken for 3 hours at r.t. The solution was 
diluted to 5 mL and then pH was exchanged to 7.4 by using dialysis (12,000 – 
14,000 Da cut-off membrane) overnight at 4 ºC. 
The solution was concentrated to 0.5 mL by centrifugation with centrifugal filter 
device (Amicon Ultra, 50000 Da cut-off membrane). Then, it was centrifuged 
with fresh PBS to remove unreacted Ru complex. The washings were performed 
until filtrated solution did not show Ru complex by UV-Vis spectroscopy 
(450nm). 
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Synthesis of D2B,Ru@Fe2O3 
 
The streptavidin-coated 1 µm beads were purchased from Thermo Fisher. The 
suspension of beads (4 µL) was washed with PBS (3 x 400 µL). The washing 
procedure consisted in a magnetic separation and a subsequent resuspension 
by gently mixing. The beads were then incubated with 400 µL of Ru(bpy)3
2+ 
biotinate complex (1 nM) for 1 h at 37 ºC with a gently mixing. The beads were 
then washed with PBS (3 x 400 µL) and after incubated with biotinated D2B 
antibody (200 µL, 1 nM) for 1 h at 37 ºC with a gently mixing. The latter 
procedure was repeated 3 times with a fresh D2B solution. The beads were 
finally washed 3 times with PBS (3 x 400 µL) and maintained in 400 µL of PBS at 
4 ºC. 
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4.5.3. Biosensor 
Assembly of PSMA biosensor 
The electrochemically induced grafting of PNSA was carried out in a single-
compartment cell by using ITO as a working electrode, platinum as counter 
electrode, and a silver spiral as a quasi-reference electrode. Electrografting was 
performed utilizing a solution of NSA 0.1 M and TBAH 0.05 M in 3 mL of 
deareated DMF, scan rate 0.1 V/s. The potential was cycled for 20 times until 
the reduction of the monomer (-2.1 V). Before polymerization, the solution was 
degassed with argon for 15 min, and then the measurement was carried out 
under Ar flux.  
After PNSA electrografting, the electrochemical cell was assembled and used 
like an ELISA well. Initially, a solution of CNTs functionalized with Ab 7E11c
 
(40 
μL) and a catalytic amount of EDC were incubated on the polymerized electrode 
overnight at 4 ºC. Then, unbound CNTs were removed by rising thoroughly with 
0.05 % Tween-20 in PBS and only PBS buffer for 2 min each. In order to block 
the free antibody binding sites on the sensor surface, the assembly was 
incubated with 40 μL of 5 % Milk in 0.05 % Tween-20/PBS for 1 h at 37 ºC, 
followed by washing with 0.05 % Tween-20 in PBS and only PBS buffer for 2 min 
each. For PSMA measurements, the sensors were then incubated with 20 μL of 
several concentrations of PSMA cell lysates for 2 h at 37 ºC. To reach the desired 
PSMA concentrations, the lysates were diluted in PSMA free lysate. Finally, after 
the washing steps, the sensor was exposed to 20 μL of the detection probe 
(D2B-Ru or D2B,Ru@Fe2O3, 1.4 mg/mL) for 2 h at 37 ºC followed by washing 
with 0.05 % Tween-20 in PBS and only PBS buffer for 2 min each. 
For the conventional immunosensor setup, 20 μL of a solution of only 7E11c 
(0.20 mg/mL) and a catalytic amount of EDC were incubated on the polymerized 
electrode and left on the surface overnight at 4 ºC.  
Electrochemiluminescence detection 
The ECL measurements were carried out in PBS (pH 6.8) 0.2 M using 200 mM 
TPA as a sacrificial co-reactant. The working electrode consisted of the modified 
ITO (as previously described) with a constant active area of 0.5 cm in diameter, 
while the counter electrode was a platinum spiral and the reference electrode 
was Ag/AgCl 3 M KCl.  
The ECL signal generated by performing the potential step program was 
measured with a photomultiplier tube (PMT, Hamamatsu R4220p) placed, at a 
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constant distance, under the cell and inside a dark box. A voltage in the range 
750 mV was supplied to the PMT. The light/current/voltage curves were 
recorded by collecting the preamplified PMT output signal (by an ultralow-noise 
Acton research model 181) with the second input channel of the ADC module of 
the AUTOLAB instrument. 
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General conclusions and 
future perspective 
 
The covalent difunctionalization of CNTs and subsequent modification of the 
introduced functional groups was presented in Chapter 2. DWCNTs were 
difunctionalized through aryldiazonium reaction, incorporating to their outer 
wall two molecular moieties which only differ on the protecting group of an 
amino function. Two different approaches were followed: the sequential 
addition and the one-pot difunctionalization. A successful result was obtained 
after the proper modification of functional groups of the material obtained by 
one-pot difunctionalization, affording a final material containing 0.52 µmol/g of 
anti-PSMA antibody and free amino groups. In addition, ox-MWCNTs were 
difunctionalized following a non-competitive approach. By the combination of 
the aryldiazionium addition and the amidation of carboxylic groups, ox-
MWCNTs functionalized with the anti-PSMA 7E11c antibody were obtained. In 
this case, FD with antibody of 3 µmol/g was obtained, a higher value than the 
DWCNTs. 
In Chapter 3, the functionalization of different graphene derivatives was 
described. Several approaches were studied with varying results. We succeeded 
in the non-competitive difunctionalization of GO with in situ reduction to rGO by 
addition of sulfur radicals to GO, followed by the amidation of residual 
carboxylic groups present in rGO. After the modification of the introduced 
functional groups, we obtained a material containing a high functionalization 
with anti-PSMA antibody and primary amino groups. This final rGO containing 
2.3 µmol/g of antibody is an excellent candidate for the building of the 
biosensor device. Finally, the non-covalent modification of ITO/CVDG was 
studied. 
In the final chapter, the preparation of a biosensor was performed using 
difunctionalized CNTs. The obtained biosensor showed good response when 
difunctionalized ox-MWCNTs were employed, with a linear correlation between 
the analytical signal and the PSMA and excellent LOD and LOQ (0.88 ng/mL and 
2.60 ng/mL, respectively) within the desired concentration range for clinical 
applications. Moreover, a second biosensor with difunctionalized DWCNTs was 
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developed. However, the results obtained with the ox-MWCNTs-based 
biosensor were not improved with the DWCNTs-based biosensor. 
As future perspective, an optimization of the use of the D2B,Ru@Fe2O3 beads as 
detection probe will be studied. In addition, in order to validate the biosensor 
performance, further experiments will be addressed, such as studying the 
electrochemical behavior at the different steps of the immunosensor assembly 
(bare ITO, ITO covered with electrografted PNSA, ITO with electrografted PNSA 
covalently linked to the CNTs).  
Subsequently, the prepared functionalized rGO (see Chapter 3) should be used 
for the preparation of new immunosensors. At this point, a comparison of the 
different sensors using CNTs and a graphene derivative will be carried out.  
Finally, as promising goal, the use of ITO/CVDG (see Chapter 3) for the 
construction of the immunosensor will be addressed. In order to achieve this 
future goal, the covalent functionalization of ITO/CVDG will be exploited, 
searching a stable interface with a compromise between a sufficient FD with 
antibody and the defects introduced during the functionalization process. In 
addition, using ITO/CVDG for the preparation of the immunosensor should 
overcome several current problems of our ECL system. For instance, the use of 
the insulating layer of PNSA could be avoided, allowing a better electrical 
communication between the electrode and CVDG. As consequence, potentials 
lower than 1.7 V could be used for the production of ECL, avoiding possible 
undesired side reactions. 
In summary, we aim of the manufacture of novel ECL immunosensors based on 
different CNMs (ox-MWCNTs, DWCNTs, rGO and CVDG), hopefully achieving 
very low LOD for the detection of PSMA. 
 
